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1.1 Natural Products 
Natural products, or secondary metabolites, are organic compounds that are 
formed by plants and animals and have no apparent function within the organism.1 
A limited number of species produce secondary metabolites. These compounds 
attract scientific interest because they usually exert an influence over other living 
organisms; often playing a part in directing interactions between plants, 
microorganisms, insects and animals. Defence chemicals, anti-feedants, attractants 
and pheromones are all natural products.2 Mankind has been using plant extracts 
to soothe ailments since ancient times; in fact it is estimated that over 40 % of 
medicines currently in use originated from natural products and their derivatives.2 
 
Marine natural products have become an increasingly popular field of research 
over the past 40 years. Over 12 000 novel compounds have already been 
described from marine plants, microorganisms and animals,3 yet the marine 
environment remains relatively unexplored in comparison to its terrestrial 
counterpart.4  
 
The ocean provides potential for a pool of structurally diverse natural products as 
34 of the 36 phyla are represented in the biodiversity of the marine environment.3 
This biodiversity gives rise to ecological pressures due to factors such as 
competition for space, food and reproductive success as well as prevention of 
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overgrowth and predation. The result of this is the evolution of a large range of 
natural products with various degrees of biological activity and unique actions.3 
The occurrence of natural products is most common in soft-bodied sessile 
organisms, a lower occurrence is seen in mobile and/or armoured animals which 
have alternative means of defence.5 Marine natural products need to be extremely 
potent, since they are rapidly diluted by the medium that they are in. This suggests 
drugs based on marine natural products have the potential to be more efficient and 
specific than many of the drugs used currently.6 Programmes set up with the aim 
to discover marine based natural products, such as that run by the National Cancer 
Institute (NCI) of the National Institute of Health (NIH) in the United States of 
America (USA), have already resulted in the discovery of several clinically useful 
drugs as well as possible drug leads and pharmacological tools.3 The majority of 
recent natural product investigations that give rise to new leads into anticancer 
drugs come from research into marine sources.7  
 
1.2 Biology of Bryozoans 
The phylum Bryozoa contains exclusively aquatic sedentary animals. Species are 
found in fresh and brackish water although they are predominantly marine.8,9 The 
name for the phylum, Bryozoa, was coined because of the moss-like appearance 
of the colonies of these animals, the term Ectoprocta (from the Greek ecto-
outside, procta-anus) has been used in the literature instead of Bryozoa by some 
authors.8 There are over 4 000 living species in this phylum and many more that 
have been observed in fossil records dating back to the early Palaeozoic period.10  
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Although a few are solitary, most bryozoan species form colonies (also called 
zoarium)11 that are made up of large numbers of intercommunicating individuals 
called zooids. The zooid structure, illustrated in Figure 1.1, has little variation 
between species. Bryozoans are widely distributed throughout the oceans of the 
world, typically in the littoral zone of the continental shelf but they are also found 
down to the depths of the ocean and in the intertidal region.11 Being filter feeders, 
bryozoans require food-bearing water but are not restricted to depths penetrable 
by sunlight. Their global distribution is also as diverse; bryozoans are found from 
polar regions to tropical waters.11 The range of habitats is so great due to the 
ability of the larvae to travel on ocean currents, attached to floating debris or 
migrating animals.11  
 
Figure 1.1: A Typical Structure of a Bryozoan Zooid.12 
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The minute size of bryozoans means that they have no need for internal transport 
systems, for example a circulatory system. Transport of nutrients is accomplished 
by movement of the coelomic fluid or by diffusion.12 The surface area to mass 
ratio is such that gas exchange and excretion of ammonia can be performed at the 
surface, therefore there is no need for excretory or gas exchange organs either.12  
 
A colony grows by asexual reproduction or budding from a primary zooid that is 
formed by the metamorphosis of a sexually produced larva.12 Bryozoans are 
typically hermaphrodites. The gonads shed gametes into the coelom, the sperm 
exits through pores found at the end of the tentacles whereas eggs exit through a 
specific pore at the base of the tentacle.12  
 
All zooids have a similar body plan but the formation of colonies has no set 
arrangement. There can be huge variation in the appearance of colonies between 
different species. Colonies are normally anchored by the substratum; the zooids 
grow upward from this in varying arrangements.9 The texture of a bryozoan 
colony can vary greatly between species. Some bryozoans are heavily calcified 
making them completely rigid whereas others can be soft or even gelatinous such 
as some Alcyonidium species.9 
  
The zooids have belts of tentacles, that emerge for feeding, with beating cilia that 
direct flow toward the mouth.9 These tentacles are part of the lophophore, which 
is typically funnel shaped and protrudes from the skeletal encasement by elevated 
pressure of the coelomic fluid.12  
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The phylum Bryozoa has three classes divided into different orders as seen in 
Figure 1.2. 
Phylum  Class   Order 
Bryozoa  I Phylactolaemata  
   II Stenolaemata II.1 Cyclostomata 
      II.2 Cystoporata 
      II.3 Trepostomata 
II.4 Cryptostomata 
   III Gymnolaemata III.1 Ctenostomata 
      III.2 Cheilostomata 
Figure 1.2: Classification of the Phylum Bryozoa. 9 
 
1.3 Natural Products Isolated from Bryozoans 
Bryozoans have been shown to produce many secondary metabolites that are 
structurally diverse.13 A comprehensive review of natural products from 
bryozoans was published in 1985.10 Another comprehensive review of alkaloids 
from marine bryozoans was published in 2001.14 Reviews detailing the available 
research on marine natural products, classified by phylum, have been published 
yearly in Natural Product Reports.15-35 A discussion of the literature concerning 
natural products obtained from marine bryozoans is presented here. 
 
The bryostatins are based on a 26 membered ring system called a bryopyran 
system10 and are probably the most well known natural products isolated from a 
bryozoan. Fourteen years after the Pettit group found that extracts from Bugula 
neritina exhibited excellent antineoplastic activity, they reported the isolation and 
X-ray crystal structure of bryostatin 1 (1).36 Since the isolation of bryostatin 1(1), 
Pettit’s group have isolated bryostatins 2-18 (2-18) from a range of collections 
from the Californian coast, the Gulf of California (Mexico), the Gulf of Mexico 
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and the Gulf of Sagami (Japan).36-41 The structures of these compounds (2-18) 
were elucidated using one-dimensional (1D) and two-dimensional (2D) nuclear 
magnetic resonance (NMR) techniques, various forms of mass spectrometry (MS) 
including solution phase secondary mass spectrometry (SPSMS) and chemical 
methods such as acid catalysed hydrolysis and selective acetylation, dehydration 
and oxidation experiments. Bryostatins are typically present in ca 10-6 % -10-8  % 
dry weight. 42 
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While bryostatins 1-3 (1-3) were found in animals collected from the Californian 
coast, bryostatins 4-7(4-7) were found in collections from the Gulf of California 
(Mexico), the Gulf of Mexico and the Gulf of Sagami (Japan) with little evidence 
of bryostatins 1-3 (1-3) being present.36 Bryostatin 3 (3) was found to be identical 
to bryostatin 1 (1) except for a profound change on the bryopyran C ring. 
Bryostatins 10 (10), 11 (11) and 16-18 (16-18) are 20-desoxy bryostatins.40 
 
Unlike the other bryostatins, bryostatin 8 (8) was first isolated from a collection of 
Amathia convoluta which also contained bryostatins 4-6 (4-6).43 Investigation into 
a relationship between the two species revealed that B. neritina colonies were 
seen growing from A. convoluta samples in a parasitic or epiphytic manner in 
amounts up to 3 % dry weight.43 Bryostatin 8 (8) was found in high enough levels 
in A. convoluta that it was concluded that this organism and not the invading B. 
neritina was responsible for producing it. It was unclear if the same could be said 
for bryostatins 4 (4) and 6 (6). 
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Bryostatin 19 (19) was isolated from a collection of B. neritina from the South 
China Sea and the structure was attained based on chemical evidence and 
spectroscopic data. It has significant antineoplastic activity against U937 cells 
(ED50 2.8 x 10-3 μg/mL) as well as against HL-60 and K562 leukaemia cells in 
vitro.44 Bryostatin 20 (20) was found in a collection of larvae of B. neritina and 
the structure was determined by spectral comparison with previously described 
bryostatins.45  
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These molecules offer a challenge to synthetic chemists. The first total synthesis 
of bryostatin 2 (2) was reported in 1998.46 Bryostatin 3 (3) has been synthetically 
prepared by a Japanese group47 and a full synthesis of bryostatin 7 (7) has also 
been accomplished.39 
 
All of the bryostatins possess antineoplastic activity. Bryostatin 1 (1) has an ED50 
value of 0.89 μg/mL against the P388 in vitro cell line,48 while bryostatins 16-18 
(16-18) showed significant growth inhibitory activity against the P388 cell line, 
(ED50 values 9.3 x 10-3 μg/mL, 1.9 x 10-2 μg/mL and 3.3 x 10-3 μg/mL 
respectively).40 Bryostatin 1 (1) in the crystalline state exhibits a large oxygen rich 
cavity and it has been suggested that this could give it antibiotic potential.10 
 
Bryostatins A and B have been found in a sample of the yellow sponge 
Lissodendoryx isodictyalis.36 Full characterisation was not possible due to 
insufficient quantities (only 900 μg of bryostatin A and 600 μg of bryostatin B 
were isolated),36 but there is evidence that these are desoxybryostatin 5 and 4 
respectively.42 Later examinations of L. isodictyalis samples were found to 
contain up to 5 % by weight B. neritina which indicated a possible symbiotic 
relationship.36 
 
Due to the cytotoxicity and antitumour activity of bryostatin 1 (1), investigations 
have been carried out into its mode of action. Results indicate that it interacts with 
protein kinase C (PKC). Bryostatin 1 (1) bound PKC is translocated to the cell 
membrane, where it is then down regulated and degraded.49  
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Some evidence suggests that PKC modulation is not the only pathway by which 
bryostatins exhibit their cytotoxicity; Protein kinase D has also been implicated in 
mediating some of the activity of the bryostatins.49 Bryostatin 1 (1) has been 
shown to cause reversal of multi-drug resistance (MDR) in some cancer cell 
lines49 and research has demonstrated that it has influence over the immune 
system. 49 Results from preclinical trials illustrated that bryostatin 1 (1) possessed 
activity in vitro and in vivo against leukaemia, lymphoma, melanoma and lung 
cancers.50 The first clinical trial started in 1990 and since then bryostatin 1 (1) has 
been in over eighty Phase I and Phase II trials51 and is currently still in one Phase 
I trial and two Phase II trials.52 
 
A study into possible biosynthetic precursors and degradation products of the 
bryostatins resulted in the isolation and characterisation of neristatin 1 (21). 
Neristatin 1 (21) does not possess a bryopyran ring and crystallisation attempts 
showed it to be a lot less stable than the bryostatins. Neristatin 1 (21) is only 
weakly active against the P388 cell line (ED50 of 10 μg/mL) and although it also 
has affinity for PKC, this affinity is two orders of magnitude less than that of 
bryostatin 4 (4).53 
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It has been shown that the bryostatins are produced by a symbiotic bacterium 
Endobugula sertula that is found in B. neritina.54 The bryostatins are produced in 
the larval stages of B. neritina and protect them against predation by fish.  
Bryostatins deter feeding by a common planktivorous fish that co-occurs with B. 
neritina but adult colonies are not protected by the bryostatins. B. neritina larvae 
hold rod shaped bacteria within a surface invagination called a pallial sinus.54 
Evidence for the bacterial production of bryostatins was reported from an 
experiment where a group of larvae was treated with antibiotics to kill their 
population of E. sertula. The treated group were shown to be significantly more 
palatable to fish compared with the control group. High performance liquid 
chromatography (HPLC) analysis of the treated group showed no sign of any 
bryostatins present.54 
 
Pettit has also described a family of β-phenyl ethylamine alkaloids, 
convolutamines A-E (22-26) and the biosynthetically related convolutamides A-F 
(27-32) from the Floridian bryozoan Amathia convoluta.43  
Chapter 1 Introduction 14 
O
Br
Br
R1
N
OHR2
O
BrBr
Br
R
N
O
N
O
HO
(22) R1 = Br, R2 = Me
(23) R1 = H,  R2 = Me
(24) R1 = Br, R2 = H
(25) R=
(26) R=
 
            
N
O
C
Br
Br
HO
HO
(27) R = (CH2)12CH3
(28) R = (CH2)7CH=CH(CH2)5CH3
(29) R = (CH2)14CH3
(30) R = (CH2)7CH=CH(CH2)7CH3
(31) R = (CH2)16CH3
(32) R = (CH2)6CH=CH(CH2)10CH3
R
O
 
This same bryozoan was later shown to yield convolutamines F (33) and G (34).55 
Convolutamine F (33) showed activity against KB, KB/VJ-300 and U937 cell 
lines with IC50 values of 27, 9.6 and 13 μg/mL respectively. It also possessed 
inhibitory activity against fertilised sea urchin eggs with an IC50 value of 82 
μg/mL.55 Convolutamides possess a rare γ-lactam and a dibromophenol ring 
system. These two classes of compounds are moderately cytotoxic against L1210, 
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KB, P388, KB/VJ-300 and U937 cell lines with IC50 values in the range of 2-10 
μg/mL.  
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Convolutamydines A (35),56 B-D (36-38)57 and E (39) 55 were also isolated from 
this species. These compounds are a series of dibromohydroxyindole alkaloids. 
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Convolutamydines A-B (35-36) were shown to inhibit differentiation of HL-60 
cells at concentrations of 0.1-2.5 μg/mL.56,57 
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Volutamides A-E (40-44) were also isolated from a sample of A. convoluta 
collected from the temperate Atlantic coast of North Carolina, USA. These 
compounds have anti-feedant activity against generalist predators such as the 
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omnivorous pinfish Lagodon rhomboides. They are also anti-fouling agents, being 
toxic to the larva of a co-occurring hydroid. The structures of these compounds 
resulted from evidence gathered by NMR spectroscopic experiments, mass 
spectrometry and chemical methods.58 
 
The tambjamines are a family of bipyrrole-based metabolites. Tambjamines A-D 
(45-48) were isolated from the bryozoan Sessibugula translucens. They have also 
been isolated from other organisms, including nudibranchs and ascidians that feed 
on this bryozoan.59 The tambjamines have promising antitumour activity and have 
been shown to bind and facilitate the cleavage of DNA in the presence of copper 
(II) and molecular oxygen.60  
N HN
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(51) Br H CH2CH3   
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(54) Br H CH2CH(CH3)CH2CH3 
   
Four tambjamines, A (45), C (47), E (49) and F (50) were also found in the 
ascidian Atapozoa sp.61 Blackman identified four novel tambjamines, 
tambjamines G-J (51-54), as well as known tambjamines C and E (47 and 49) 
from a Tasmanian collection of the bryozoan Bugula dentata.62 
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Because of the widespread occurrence of these alkaloids, it has been proposed that 
they are of microbial origin, however Lindquist and Fenical have indicated that 
the ascidian Atapozoa sp. may be capable of de nove tambjamine biosynthesis 
based on a microscopic examination of this animal. It has been reported that the 
nudibranch obtains tambjamines from the ascidian and they both use them as a 
form of chemical defence.61 
 
A tetrapyrrole blue pigment (55) has also been isolated from B. dentata. This 
compound displays antimicrobial activity.63 
N
O
N
HNH
N
H
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Chartelline A (56) was isolated from the marine bryozoan Chartella papyracea 
which is closely related to Flustra foliacea.10 MS, NMR spectroscopy and X-ray 
crystallography were used to establish the structure of chartelline A (56) which 
appears to be composed of modified tryptamine and histamine residues linked via 
an isoprene unit, as is suggested by the literature.64 Chartellines A-C (56-58) as 
well as chartellamides A and B (59-60)65 have been isolated from this species. 
Chartellines are β-lactam indole alkaloids that only differ in the number and 
position of the bromo substituents. These compounds exhibited no significant 
biological activity in antimicrobial and antitumour assays.66 A recent attempt at 
total synthesis of chartelline A (56) was unsuccessful due to the resulting product 
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having a 7-membered ring instead of the 10-membered ring seen in the natural 
product.67  
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Securamines and securines are a class of halogenated indole-imidazole alkaloids 
that have been isolated from the marine bryozoan Securiflustra securifrons 
collected from the North Sea. Securamines A (61) and B (62) are in equilibrium 
with securines A (63) and B (64) respectively when dissolved in DMSO-d6.68 The 
biosynthesis of these alkaloids appears to originate from the modification of 
tryptamine, histamine and isoprene units. These compounds were structurally 
determined using NMR spectroscopy and MS and combine structural features of 
the flustramines with some of those from the chartellines. Securamines A-B (61-
62) only differ in the presence (62) or absence (61) of a bromine substituent in the 
benzene ring, as do C (65) (present) and D (66) (absent). Securamines C-D (65-
66) appear to be derived from securamines A-B (61-62) via the attack of the 
indole nitrogen at C8 of the imidazole ring. 68  
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Three new securamines E-G (67-69) were isolated from the same bryozoan and 
structurally determined using NMR spectroscopic and MS techniques. These three 
compounds are structural variations of securamine C (65). Securamine E (67) has 
an extra bromine substituent on the indole ring system, while securamine F (68) is 
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a diastereoisomer differing in configuration at one of the four asymmetric carbon 
centres and securamine G (69) is a hydrogenated form of securamine C (65).69 No 
biological activity was reported for these compounds. 
 
Amathia wilsoni is another bryozoan from which a number of secondary 
metabolites have been isolated. Amathamides A-B (70-71) were isolated from a 
Tasmanian collection of this bryozoan. The structures of these two compounds 
were determined using high resolution mass spectrometry (HRMS) and NMR 
spectroscopic data.70 Amathamides are brominated proline-derived alkaloids. 
Further studies have resulted in the isolation of amathamides A-F from A. wilsoni 
(70-75).71 Amathamide G (76) was isolated from the closely related species A. 
convoluta.72 
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Amathaspiramides A-F (77-82) were isolated from a New Zealand collection of 
Amathia wilsoni.73 A combination of spectroscopic data and X-ray 
crystallography was used to establish the structures of these compounds including 
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absolute configuration. Amathaspiramide E (81) shows strong activity against the 
Polio virus type I. No amathamides were present in this collection.73 
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Alternatamides A-D (83-86), four bromotyptamine peptides, were isolated from 
the marine bryozoan Amathia alternata. The structures of these were established 
predominantly with 2D NMR spectroscopy but also with MS and 1D NMR 
spectral information.74 
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Alternatamides A-C (83-85) show modest antibacterial activity against 
Staphylococcus aureus, S. epidermidis, S. haemolyticus, Bacillus subtilis, 
Enterococcus faecalis, E. faecium, and Streptococcus pyogenes with minimum 
inhibitory concentration (MIC) values ranging between 4 and 32 μg/mL. These 
compounds do not show any activity against Gram-negative bacteria. 
Alternatamide D (86) was not tested.74 
 
Three novel brominated quinone methides, euthyroideones A-C (87-89) were 
isolated from a New Zealand collection of the bryozoan Euthyroides episcopalis. 
The structures of these three compounds were determined using MS, NMR 
spectroscopic data and X-ray crystallography.75 
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Secondary metabolites from bryozoans have a large variety of structures. A 
unique C21 tetracyclic terpenoid lactone, murrayanolide (90), was isolated from 
Dendrobeania murrayana. Terpenes are not commonly found in bryozoans but 
murrayanolide is thought to be biosynthesised by the degradation of a higher 
terpenoid chain.76 
OO
O
O
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An Indo-Pacific collection of the marine bryozoan Caulibugula intermis led to the 
isolation of six novel cytotoxic isoquinoline quinones and iminoquinones. 
Bioactivity directed fractionation guided the isolation of caulibugulones A-F (91-
96). The structures of these compounds were determined by spectrochemical 
analysis including liquid chromatography-mass spectrometry (LCMS), high 
resolution fast atom bombardment mass spectrometry (HRFABMS), 1D and 2D 
NMR spectroscopy as well as comparison with related compounds.77 
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Caulibugulones E-F (95-96) are thought to be the first compounds with an 
isoquinoline iminoquinone skeleton to be isolated from a natural source. 
 
N
O
O
N
H
N
O
O
N
H
N
O
O
N
H
N
NH
O
N
H
N
O
O
N
H
Br
Cl
OH
N
N
O
N
H
HO
(91) (92)
(94)(93)
(95) (96)  
 
Evaluation of the biological activity of these compounds revealed IC50 values 
ranging between 0.03 and 1.67 μg/mL against the murine IC2 cell line. 
Caulibugulones A-C (91-93) showed similar activity indicating that halogen 
substitution at C6 does not affect cytotoxicity. Caulibugulone E (95) is roughly an 
order of magnitude more cytotoxic than its corresponding isoquinoline quinone 
caulibugulone A (91). 78  
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β-Carbolines are known to occur in terrestrial plants,79 but examples have also 
been found in marine bryozoans. Two collections of the orange foliose bryozoan 
Costaticella hastata from southern Tasmania contained a range of 1-substituted β-
carboline alkaloids. The major β-carboline alkaloid in both collections was 1-
methyl-β-carboline (harman) (97). Three minor β-carbolines were also found. The 
first collection yielded 1-ethyl-β-carboline (98) and (S)-1-(1’hydroxyethyl)-β-
carboline (99) while the second collection yielded both these compounds (98-99) 
as well as a third minor constituent, 1-vinyl-β-carboline (pavettine) (100).80  
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Another marine bryozoan Cribricellina cribraria has been shown to produce both 
known and new β-carboline alkaloids. Investigation into the cytotoxic extract of 
this bryozoan revealed 1-vinyl-8-hydroxy-β-carboline (103) was the major 
component. Harman (97) and pavettine (100) were also present as well as 1-ethyl-
4-methyl-sulfone-β-carboline (104).81 These alkaloids differ significantly in their 
degree of biological activity in the P388 assay. β-Carbolines with a vinyl group at 
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C1 exhibit IC50 values of 100 ng/mL whereas those lacking this substituent are 
virtually inactive.81 Further investigation of other collections of this bryozoan 
yielded more novel β-carboline alkaloids including 6-hydroxyharman (101), a β-
carboline previously reported from terrestrial origins, and 8-hydroxyharman 
(102), the latter being a new β-carboline alkaloid. The structures of these two 
compounds were determined using NMR spectroscopy and HRMS. These 
compounds showed no significant activity against the P388 murine leukaemia cell 
line (both had an IC50 > 12500 ng/mL). 6-Hydroxyharman (101) did show activity 
against the Herpes simplex type 1 virus with no significant cytotoxicity.82 
 
The brominated indole alkaloid 2,5,6-tribromo-N-methylindole-3-carbaldehyde, 
also known as 2,5,6-tribromo-1-methylgramine (105) was isolated from a Spanish 
collection of the marine bryozoan Zoobotryon verticullatum. This extract also 
contained a number of known gramine alkaloids.83 Structural elucidation was 
based on spectroscopic information and confirmed by comparisons with synthetic 
versions.10 This compound was shown to delay metamorphosis in fertilised sea 
urchin eggs with an ED50 value roughly equal to 16 μg/mL.10 There is a taxonomic 
interest in this compound because Z. verticullatum is of the order Ctenostomata 
and an unrelated bryozoan Flustra folicea from the order Cheilostomata also 
produces similar bromoindole alkaloids.10 
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Two novel compounds have been isolated from the marine bryozoan 
Membranipora perfragilis.  These compounds, perfragilins A-B (106-107), are 
isoquinoline quinones and their structures were determined by X-ray 
crystallography. They are cytotoxic to P388 murine leukaemia cells with IC50 
values of 0.8 and 0.07 μg/mL respectively but have no antiviral activity. It has 
been suggested that these compounds are of bacterial origin because of their 
structural relationship to mimosamycin, a secondary metabolite produced by the 
terrestrial actinomycete Streptomyces lavendulae.84 
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A New Zealand collection of Pterocella vesiculosa yielded two novel cytotoxic 
compounds. Pterocellins A-B (108-109) belong to a new class of alkaloids with a 
unique tricyclic pyrido[4,3-b]indolizine ring system.85 Structural elucidation was 
achieved by NMR spectroscopy and MS data analysis as well as X-ray diffraction 
studies of pterocellin A (108).86 Both compounds exhibit potent antitumour 
activity in vitro against P388 murine leukaemia cells, but only modest activity in 
the in vivo hollow fibre assay at the NCI.86 Pterocellins C-G (110-114) have been 
isolated and characterised from the same bryozoan.87 Pterocellin A (108) has been 
synthesised.85 
 
Bryoanthrathiophene (115) was isolated from a Japanese sample of the bryozoan 
Watersipora subtorquata by bioassay guided fractionation. The structure was 
characterised using MS and NMR spectral data. This compound has 
antiangiogenic activity, so stops the formation of new blood vessels thus 
preventing the growth of tumours.88 
S
OH OHO
(115)  
  
Hinckdentine A (116) was isolated from a Tasmanian collection of the marine 
bryozoan Hincksinoflustra denticulata. Spectral analysis along with X-ray 
crystallography gave the structure with absolute stereochemistry.89 Although 
hinckdentine A (116) has not been successfully synthesised to date, both the 
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hinckdentine framework and 8-desbromohinckdentine A (117) have been 
synthesised.90 
N
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The crude extract of the marine bryozoan Pentapora fascialis showed 
antihelmintic activity against Trichenella spiralis. Bioassay guided fractionation 
led to the isolation of three new sulfur containing compounds, pentaporins A-C 
(118-120). Pentaporins A-C (118-120) were structurally determined through 1D 
and 2D NMR spectroscopy as well as mass spectral information and energy 
dispersive X-ray (EDX) analysis.91 Structure activity investigation led to the 
assumption that the sulfate ester groups are responsible for the antihelmintic 
activity of the pentaporins.91 
OSO3-S
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Phidolopin (121) is a purine derivative isolated from the marine bryozoan 
Phidolopora pacifica collected in British Columbia.92 The crude extract of P. 
pacifica showed strong in vitro antifungal and antialgal activity for which 
phidolopin (121) was largely responsible. The structure of phidolopin (121) was 
solved through X-ray crystallography with supporting evidence provided by high 
resolution electron ionisation mass spectrometry (HREIMS), NMR and infrared 
(IR) spectroscopic information.92 
 
N
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Flustra foliacea is a marine bryozoan that has yielded a vast number of secondary 
metabolites. Several monoterpenes have been isolated from F. foliacea including 
cis- and trans-citral (122-123), citronellol (124), nerol (125), geraniol (126), 
rosefuran (127) and citronellal (128).93 
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Flustramines A and B (129-130) were the first secondary metabolites isolated 
from F. foliacea. The structures were elucidated using HRMS and NMR 
spectroscopic data.94,95 They have a physostigmine skeleton and flustramine A 
possesses a rare inverted isoprene unit.94 Flustramines A-B (129-130) show strong 
muscle relaxant effects in vivo, causing 50 % inhibition of contractions of rat 
diaphragm muscle at concentrations of 59 and 63 μg/mL respectively.96 
Flustramine C (131) and flustraminols A and B (132-133) were isolated from 
another extract of F. foliacea. Their structures were determined using HRMS data, 
NMR spectroscopic information and ultra violet (UV) absorption results.97 
Another sample of F. foliacea yielded 7-bromo-4-(2-ethoxyethyl)quinoline (134), 
the first naturally occurring bromo-quinoline to be isolated. The structure of this 
compound was elucidated using HRMS, NMR spectroscopy and UV 
spectroscopy.98 
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Dihydroflustramine C (135) was identified as the principle antibacterial agent in 
an extract of F. foliacea. The structural assignment was based on mass spectral 
evidence along with NMR spectroscopic information.99 Dihydroflustramine C 
(135), its N-oxide (136), flustramine D (137), its N-oxide (138) and isoflustramine 
D (139), have been isolated from F. foliacea. It is rare to isolate N-oxides from 
marine organisms.100 An extract mixture containing mainly dihydroflustramine C 
(135) and flustramine D (137) showed activity against a wide range of bacteria in 
disk diffusion assays.100 Flustramines A and B (129-130) and dihydroflustramine 
C (135) are weakly cytotoxic against the HCT-116 cell line with IC50 values of 
roughly 10 μg/mL.101  
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Flustramide A (140) flustramide B (141) and flustrarine B (142) have also been 
isolated from F. foliacea.98,102 Structural elucidation was based on IR, MS and 
NMR spectral information. Flustrarine B (142) was synthesised by oxidation of 
flustramine B (130).102 
 
Flustramine E (143) was isolated from a North Sea sample of F. foliacea and 
characterised based on spectroscopic investigation. Debromoflustramine B (144) 
was also present in trace amounts in the same extract and was identified based on 
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comparison with a synthetic version.103 Flustramine E (143) showed marginal 
activity against Bacillus subtilis and good activity against Botrytis cinerea and 
Rhizotonia solani.103 
 
Deformylflustrabromine (145) was isolated from a North Sea collection of F. 
folicea. It appears to be a link in the biosynthetic pathway from flustrabromine 
(146) to flustraminol A (132). HRMS information along with 1D and 2D NMR 
spectroscopic data was used to determine the structure and compound (145) is 
cytotoxic to the HCT-116 cell line with an IC50 value of 1.87 μg/mL.101 
 
New natural products were reported from a North Sea collection of F. foliacea 
along with known metabolites. The three new indole alkaloids (147-149) were 
isolated and their structure determined with MS information accompanied by 1D 
and 2D NMR data and UV absorption information.104 
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Flustramines A-B (129-130), flustramides A (140) and B (141) and 
debromoflustramine B (144) have been synthesised.105 
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The number of brominated alkaloids in a single colony of F. foliacea can vary 
significantly and may be as high as eleven. Colonies at a certain location possess a 
distinct and fairly constant alkaloid profile.93 
 
A strongly cytotoxic compound (150) and its isomer (151) were isolated from an 
extract of the marine bryozoan Myriapora truncata. They are polyketide derived 
metabolites which both showed 88 % inhibition of L1210 murine leukaemia cells 
at a concentration of 0.2 µg/mL.106 
 
OOH
O
OH OH
OH
O
(150)
OHO
O
OH OHO
HO
(151)  
 
Chapter 1 Introduction 42 
1.4 Biological Assay Systems Used in this Thesis 
Biological assays were performed at the University of Canterbury. All crude 
extracts were tested for activity over the whole range of assays. Bulk extracts and 
subsequent fractions from those were tested in the P388 antitumour assay system 
only. 
 
P388 Antitumour Assay 
This assay is used to determine the concentration of the test sample required to 
reduce the P388 murine leukaemia cell line growth by 50 %, the IC50 value. The 
test solution is added to wells containing the leukaemia cells in a series of eight 
two fold dilutions, and then the cells are incubated (35 °C, 72 hours). The number 
of viable leukaemia cells is determined by adding 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) to the wells and then this is incubated for 
a further four hours. Normal leukaemia cells reduce MTT, which is a yellow 
colour, to the purple formazan product. The quantity of the formazan product is 
determined with a spectrophotometer at 540 nm. The percentage inhibition of 
P388 cell growth by a sample can be determined by comparing the absorbance of 
a test well to that of the control. A plot of absorbance against the logarithm of the 
sample concentration allows the IC50 value to be obtained (in ng/mL) from the 
antilog of the 50 % value. 
 
The Antimicrobial Assay  
The antimicrobial assay carried out at the University of Canterbury determines if a 
test solution has the ability to inhibit the growth of bacteria and/or fungi. Six 
microorganisms are used in these tests: two Gram-negative bacteria 
Chapter 1 Introduction 43 
(Pseudomonas aeruginosa and Escherichia coli) a Gram-positive bacterium 
(Bacillus subtilis) and three fungi (Candida albicans, Trichophyton 
mentagrophytes, and Cladosporium resinae). A known concentration of bacteria 
or fungi is mixed with Mueller Hinton or potato dextrose agar and poured into a 
Petri dish and a “lawn” of the microorganism growth over the dish is observed. 
Filter paper disks (6 mm diameter) are impregnated with the sample of interest 
then air dried at room temperature for twenty minutes to allow the solvent to 
evaporate. These disks, along with antibiotic and control disks are placed onto the 
seeded agar dishes. The disks are then incubated (35 °C, 24 hours for most but for 
T. mentagrophytes and C. resinae it is 48 hours). If a sample is active against the 
microorganism in that dish, there will be a zone of inhibition around the disk. The 
radius of this inhibition zone is measured to determine the extent of inhibition 
from that sample. “ND” indicates no activity was observed and an asterisk 
indicates slight activity. 
 
The Antiviral/Cytotoxicity Assay 
These assays use a continuous BSC-1 cell line derived from African Green 
Monkey kidney cells infected with either Herpes simplex type 1 virus (ATCC VR 
733) or Polio virus type 1 (Pfizer vaccine strain) to coat assay wells. A layer of 
methylcellulose is then put down to cover the well. The sample of interest is 
applied onto a paper disk 6 mm in diameter, and then the disk is air dried at room 
temperature (20 minutes) and advanced through the methylcellulose layer to be 
directly contacting the monolayer of cells. Virus and cell controls are also 
included with each run. All of the wells are incubated (35 °C, 24 hours) with a 5 
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% CO2 enriched atmosphere. The assays are viewed under an inverted microscope 
and examined for the zone of inhibition around the paper disk. Table 1.1 lists the 
abbreviations used to describe the extent of the antiviral or cytotoxic zone, while 
Table 1.2 lists the terms used to describe the cytotoxicity types. 
 
Table 1.1: Scale Used for Antiviral and Cytotoxicity (zone) Results. 
 
ND No discernable antiviral or cytotoxic zones. 
? Indeterminate activity due to strong cytotoxicity. 
?* Virus growing right up to cytotoxic zone. 
± Minor effects located under the disk. 
+ Antiviral or cytotoxic zone extending 1-2 mm radius from disk edge.  
(25 % zone) 
2+ Antiviral or cytotoxic zone extending 2-4 mm radius from disk edge.  
(50 % zone) 
3+ Antiviral or cytotoxic zone extending 4-6 mm radius from disk edge.  
(75 % zone) 
4+ Antiviral or cytotoxic zone extending over whole well.  
(100 % zone) 
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Table 1.2: Interpretation of Cytotoxicity Types. 
 
1 Tightly packed small and round cells with well defined nuclei. 
2 Cells appear elongated and stringy. 
3 A scruffy mixture of rounded and elongated cells. 
4 Well separated cells that are small and round. 
5 Clumps of rounded cells. 
6 Cells are distended and scattered throughout the whole well. 
7 Cells are slightly elongated and appear granular. 
7* Indistinct individual cells resulting in a misty appearance. 
8 Elongated cells with pronounced nuclei. 
9 Small and rounded cells with ragged edges and two prominent nuclei. 
10 Cells are extremely small and appear as dots. 
11 Enlarged cells with square ends packed together in a mosaic pattern. 
12 An enlarged version of type 3 cytotoxicity. 
 
1.5 Work in this Thesis 
A study of the bryozoan Pterocella vesiculosa resulted in the isolation and 
structural elucidation of three new novel compounds pterocellin H (188), 
pterocellin I (189) and 1-methyl-5-bromo-8-methoxy-β-carboline (190). Isolation, 
characterisation and the evaluation of the biological activity of these three new 
compounds are discussed. 
 
A survey of the biological activity and chemical components of 85 marine 
organisms was undertaken using various analytical techniques. Results indicated 
that some samples of the same species have varying chemical compositions based 
on factors such as location.   
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Results from the chemical survey led to the further investigation of two marine 
organisms including one sponge sample from the family Darwinellidae. The study 
was aimed at isolating bioactive and/or novel compounds and analysing the sterol 
composition of these organisms. Due to lack of material no novel compounds 
were isolated. 
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Chapter Two 
Studies of the Marine Bryozoan Pterocella vesiculosa 
 
2.1 Introduction 
Pterocella vesiculosa (order Cheilostomatida, suborder Ascophorina, family 
Catenicellidae) is a marine bryozoan found in the waters of the upper North Island 
of New Zealand and South Australia.86 Bryozoans are a relatively unexplored 
phylum in natural product chemistry, although many secondary metabolites with 
significant biological activity have been found from these animals. The most well 
known examples are the bryostatins. Bryostatin 1 (1) has successfully been 
through over eighty Phase I and Phase two clinical trials and is currently in one 
Phase I and two Phase II clinical trials.42,50-52  
 
The natural product research group at the University of Waikato, led by Dr. 
Michèle Prinsep, have been successful in the isolation of new metabolites from 
bryozoans. The amathaspiramides A-F (72-77),73 the euthyroideones A-C (82-
84)75 and the pterocellins A-G (108-114)86,87 have all been isolated from endemic 
bryozoan species. 
 
 
Pterocellins A and B (108-109) were isolated and characterised from a sample of 
P. vesiculosa.86 They have excellent in vitro activity against the P388 murine 
leukaemia cell line, but were inactive in the in vivo hollow fibre assay performed 
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by the National Cancer Institute (NCI).86 Pterocellins C-G (110-114) have also 
been isolated and characterised, although remain unpublished to date.87 
 
Other members of the family Catenicellidae such as C. hastata and C. cribraria 
have between them yielded six novel β-carbolines. 1-Methyl-β-carboline 
(harman) (97) and 1-vinyl-β-carboline (pavettine) (100) were common to both 
species. C. hastata also yielded (S)-1-(1’hydroxyethyl)-β-carboline (99) and 
1-ethyl-β-carboline (98)80 while C. cribraria yielded 6-hydroxyharman (101),82 
8-hydroxyharman (102),82 1-vinyl-8-hydroxy-β-carboline (103)81,107 and 
1-ethyl-4-methylsulfone-β-carboline (104).81 Many of these alkaloids had been 
isolated from terrestrial sources but the latter two were previously unknown. 
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Brominated β-carboline alkaloids have been reported from marine organisms, 
some with interesting biological activity. The series of compounds called the 
eudistomins have been isolated from organisms belonging to several families and 
genera.108-115 
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To date, eudistomins A-X (152-175)108-111 have been reported. Eudistomins A-T 
(152-171) have been isolated from the tunicate Eudistoma olivaceum.108,110 Of 
these, the structure of eudistomin B (153) has not been fully assigned, the 1H 
NMR spectroscopic data suggests that it is a 1,6,7-trisubstituted β-carboline with a 
methoxyl group.110 Eudistomins C (154), K (162) and O (166) along with 
eudistomin K-sulfoxide (176) and debromoeudistomin K (177) have been isolated 
from the tunicate Ritterella sigillinoides.113-115 Eudistomin U (172) was isolated 
from the ascidian Lissoclinum fragile along with isoeudistomin U (178).109 
Eudistomin V (173) was isolated from the ascidian Pseudodistoma aureum,112 
while eudistomins W (174) and X (175) were also isolated from a Eudistoma 
sp.111 
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A series of brominated β-carboline alkaloids, eudistomidins A-F (179-184) were 
isolated from an ascidian Eudistoma glaucus.116 Eudistomidins B-D (180-182) 
showed promising antitumour activity against the cell lines L1210 (IC50 values of 
3.4, 0.36 and 2.4 μg/mL respectively) and L5178Y (IC50 values of 3.1, 0.42 and 
1.8 μg/mL respectively).116  
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The hydroid Aglaophenia pluma has yielded three novel brominated β-carboline 
alkaloids, 6-bromo-1-methyl-β-carboline (185), 6-bromo-1-ethyl-β-carboline 
(186) and 6,8-dibromo-1-ethyl-β-carboline (187). No biological activity was 
reported for these compounds.117 
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No brominated β-carbolines have previously been reported from a bryozoan 
species.  
 
A sample of P. vesiculosa was chosen for further investigation with the aim of 
isolating a larger quantity of pterocellin G so further characterisation could be 
completed.  Pterocellin G (114) was not found in this sample but three new 
compounds, pterocellin H (188), pterocellin I (189) and 1-methyl-5-bromo-8-
methoxy-β-carboline (190) were isolated and characterised. A discussion of the 
structure-activity relationship of selected members of these classes of compounds 
is also presented.  
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2.2 Isolation and Structural Elucidation of Pterocellin H (188) 
2.2.1 Isolation of Pterocellin H (188) 
The crude dichloromethane extract of P. vesiculosa was subject to fractionation 
by reversed phase and size exclusion column chromatography monitored by TLC 
analysis. This resulted in the isolation of a fraction containing the new compound 
pterocellin H (188). The structure of pterocellin H (188) was elucidated using 
one-dimensional (1D) and two-dimensional (2D) NMR spectroscopic techniques 
and high resolution electrospray mass spectrometry (HRESMS). The separation 
tree for this extract is presented in Appendix Five. 
 
2.2.2 Characterisation of Pterocellin H (188) 
The 1H NMR spectrum of pterocellin H (188) in CDCl3 (Figure 2.1) contained ten 
signals. These signals included four aromatic proton signals (two singlets at 6.57 
and 7.81 ppm and two mutually coupled doublets at 7.30 and 8.39 ppm). A methyl 
signal at 2.00 ppm, a methoxyl resonance (3.74 ppm), two methylene signals at 
3.31 ppm and 3.02 ppm, a methine proton multiplet at 2.17 ppm and a doublet at 
1.02 ppm were also present.  
 
The 13C NMR spectrum of pterocellin H (188) in CDCl3 contained eighteen 
carbon signals. Four signals represented protonated aromatic carbons, while there 
were also six quaternary aromatic carbon resonances, and two carbonyl signals at 
172.5 ppm and 205.0 ppm. Of the six aliphatic protonated carbon resonances, the 
signal at 22.4 ppm was significantly more intense than the others, indicating that it 
represented two carbon atoms. 
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The HRESMS of compound (188) contained a [M+Na]+ peak at m/z 365.1512, 
with no obvious isotope pattern and the [M+H]+ ion was also visible at m/z 
343.1692. These two peaks are consistent with the molecular formula C19H22N2O4 
for pterocellin H (188). 
 
Atom connectivity was established by COSY, 1H-13C HSQC and 1H-13C HMBC 
NMR spectroscopic experiments, as well as by comparisons with molecules of 
closely related structure. For example, the proton signals at 3.02, 2.17 and 1.02 
ppm show correlations that indicate they form an isobutyl group as depicted in 
Figure 2.2. The correlations seen in the HMBC NMR experiment from H1’ to C1 
and C13 and from H2’ to C1 indicate that the isobutyl group is attached to the C1 
position. 
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Figure 2.2 COSY and HMBC Interactions of a Substructure of Pterocellin H 
(188). 
 
The HMBC NMR spectroscopic data indicates that the two aromatic proton 
signals at 6.57 and 7.81 ppm represent protons that are positioned para to each 
other. HMBC NMR correlations are seen from H8 to C9 and C10 and also from 
H11 to C9 and C10. The methoxyl group is attached at C10 as indicated by the 
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HMBC correlation from H14 to C10, which was the only HMBC correlation 
observed for H14.  This leads to the fragment structure depicted in Figure 2.3. 
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Figure 2.3: HMBC Interactions of a Pterocellin H (188) Fragment. 
 
The proton resonances of H1” and H3” (3.31 and 2.01 ppm respectively) show 
correlations in the 2D NMR experiments that indicate they are part of a propanoyl 
sidechain attached at C6. The HMBC NMR spectrum contains a correlation from 
H3” to C2”, the carbonyl carbon, and C1”, it also shows correlations from H1” to 
C2” indicating that the carbonyl is positioned between these two. Additional 
correlations are observed in the HMBC experiment from H1” to both C6 and to 
the quaternary aromatic signal of C7, indicating that this propanoyl group is 
attached at the C6 position.  
H2C CH3
O
1" 3"
2"
 
 
Figure 2.4:  HMBC Correlations of the C6 Sidechain of Pterocellin H (188). 
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The NMR spectroscopic data, along with comparisons with reported data on 
closely related compounds, indicates that pterocellin H (188) possesses the same 
skeleton common to the pterocellin series of compounds and has an isobutyl 
group at position 1 and an hydroxyl group and a propanoyl side chain at position 
6. 
N N
O
HO
O
O
(188)
 
 
The NMR spectroscopic data for pterocellin H (188) is summarised in Table 2.1 
The resonance of the C6 carbonyl group in pterocellin A is 184.3 ppm,86 the 
replacement of this carbonyl group with a hydroxyl group and a propanoyl group 
shifts the resonance significantly upfield to 75.9 ppm as is seen in pterocellin H. 
The proton resonance of H8 seen at 7.07 ppm in pterocellin A86 is also moved 
significantly upfield to its position at 6.57 ppm in the 1H NMR spectrum of 
pterocellin H. 
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Table 2.1: 1H and 13C NMR Spectroscopic Data for Pterocellin H (188) Recorded
 in CDCl3.  
N
O
O
N
3'
4'
2'1'
1
3
4
5
6
7
8
9
1014
11
13
1" 2" 3"
HO
O
(188)  
Position 1H δ (ppm) (J, Hz) 13C δ (ppm)  HMBC (H to C) 
1     145.2 
3  8.39 d (4.6)  146.5   1, 4,  
4  7.31 d (4.6)  117.1   3, 6, 13 
5     145.5 
6       75.9  
7     149.6  
8  6.57 s   111.8   6, 7, 9, 10 
9     172.5  
10     153.3 
11  7.76 s   115.8   7, 9, 10, 13   
13     136.1 
14  3.74 s     56.5   10 
1’  3.00 d (7.2)    44.6   1, 13, 2’, 3’/4’ 
2’  2.17 m     28.4   1’, 3’/4’ 
3’  1.02 d (6.5)    22.4   1’, 2’, 4’ 
4’  1.02 d (6.5)    22.4   1’, 2’, 3’ 
1a”  3.37 d (18.0)      52.1   6, 7, 2”  
1b”  3.26 d (18.0)       52.1   6, 7, 2”  
2”     205.0   
3”  2.01 s     30.7   1”, 2” 
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2.3 Isolation and Structural Elucidation of Pterocellin I (189) 
2.3.1 Isolation of Pterocellin I (189) 
TLC directed fractionation of the crude extract of P. vesiculosa led to the isolation 
of a fraction containing pterocellin I (189). The structure of pterocellin I (189) 
was determined by HRESMS and 1D and 2D NMR spectroscopic data analysis. 
 
2.3.2 Characterisation of Pterocellin I (189) 
The 1H NMR spectrum of pterocellin I (189) in CDCl3 (Figure 2.5) strongly 
resembled that of pterocellin H (188) but the resonances for the isobutyl group 
were absent, replaced by a methylene singlet at 4.64 ppm and extra signals in the 
aromatic region consisting of a three-proton multiplet at 7.34 ppm and a 
two-proton doublet at 7.16 ppm. 
 
The 13C NMR spectrum of pterocellin I (189) contained twenty carbon 
resonances. Seven of these signals were aromatic protonated carbons, two of 
which were considerably more intense than the others, indicating that they each 
represented two carbon atoms. There were two carbonyl carbon signals at 172.4 
ppm and 204.9 ppm. The spectrum also contained four aliphatic carbon signals 
and seven quaternary aromatic carbon signals. Of these resonances, most were 
analogous to those seen in the 13C NMR spectrum of pterocellin H. The 
resonances of the carbon atoms from the isobutyl group in pterocellin H (188) 
were absent and there were five additional resonances representing an aromatic 
quaternary carbon, three protonated aromatic carbons and a protonated aliphatic 
carbon.  
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The HRESMS of compound (189) contained a [M+Na]+ peak at m/z 399.1240, 
with no obvious isotope pattern, the [M+H]+ ion was also visible at m/z 377.1436. 
These two peaks are consistent with the molecular formula C22H20N2O4 for 
pterocellin I (189). 
 
The differences in the 1H and 13C NMR spectra between pterocellin H and 
pterocellin I indicate that the isobutyl substituent at C1 in pterocellin H is replaced 
by a benzyl group in pterocellin I. COSY, 1H-13C HMBC and 1H-13C HSQC NMR 
data were used to establish the connectivity of the new atoms. The COSY NMR 
spectrum contained correlations between the multiplet of H4’/H5’ and the 
resonance of H3’. The HMBC NMR spectrum contained correlations from H1’ to 
both C1 and C13, indicating the sidechain attachment at position 1, in addition to 
a correlation to the quaternary aromatic signal of C2’ (137.0 ppm). The HMBC 
spectrum also contained correlations from H3’ and H4’/H5’ to C2’ indicating the 
benzyl sidechain as depicted in Figure 2.6.  
H2C
3'
4'2'
1'
5'3'
4'
H
H
H
H
H
1
13
 
Figure 2.6: C1 Sidechain of Pterocellin I (189) with HMBC Interactions. 
 
Other correlations observed in the HMBC NMR spectrum indicated that this 
compound possessed the same skeleton as pterocellin H with the same 
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substitution of groups except that the benzyl group replaced the isobutyl group at 
C1. This allowed complete structural elucidation of pterocellin I (189). 
 
N N
O
HO
O
O
(189)
 
 
A summary of the NMR data for pterocellin I (189) is presented in Table 2.2. 
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Table 2.2: 1H and 13C NMR Spectroscopic Data for Pterocellin I (189) in CDCl3 
N
O
O
N
3'
4'
2'1'
1
3
4
567
8
9
1014
11
13
1"
2" 3"
HO
O
5'
(189)  
 
Position 1H δ (ppm) (J, Hz) 13C δ (ppm)  HMBC (H to C) 
1     145.9 
3  8.53 d (4.6)  147.0   1, 4,  
4  7.45 d (4.6)  117.8   3, 6, 13 
5     142.6 
6       76.0  
7     149.6  
8  6.56 s   111.3   6, 7, 9, 10 
9     172.4  
10     152.8 
11  7.76 s   115.7   7, 9, 10, 13   
13     136.7 
14  3.34 s     56.1   10 
1’  4.64 s     41.9   1, 13, 2’, 3’ 
2’     137.0    
3’  7.16 d (7.2)    127.8   1’, 2’, 4’, 5’ 
4’  7.34 m   129.3   2’, 3’, 5’ 
5’  7.34 m   127.3  
1a”   3.39 d (18.3)        52.2   6, 7, 2”  
1b”   3.28 d (17.8)      52.2   6, 7, 2”  
2”     204.9   
3”  2.08 s     30.6   1”, 2” 
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2.4 Biological Activity of the Pterocellins. 
The pterocellin series of compounds show activity in the P388 antitumour assay 
and also in two of the antimicrobial assays performed at the University of 
Canterbury (for assay details see Section 1.4). Table 2.3 outlines the biological 
activity of the pterocellins in these assay systems. Biological assay information 
for pterocellins A-F (108-113) has been previously obtained.86,87 
 
Table 2.3: Biological Activity of Pterocellins A-I. 
Pterocellin   P388   Bsa     Tmb 
 IC50 (ng/mL) MID (μg/disk)  MID (μg/disk) 
   
 A (108)  477  0-0.3     3.9-7.5  
 B (109)  323  0-0.3     3.9-7.5 
 C (110) c  >6250    0-0.5     ND d 
 D (111)  4773  0.5-1  10-15 
 E (112) c >6250   0-0.5     ND 
 F (113) c >6250   0-0.5     ND 
 G (114)  not yet tested 
   H (188)  >6250      ND  ND 
I (189)   >6250      ND  ND 
a Bacillus subtilis, b Trichophyton mentagrophytes, c MID values yet to be 
confirmed,  d no activity was observed. 
 
It is evident that pterocellins A (108) and B (109) are the most active of this series 
of compounds. Based on the information in Table 2.3 there appear to be 
relationships between the structures of the pterocellins and the activity they 
exhibit. All pterocellins tested to date display antibacterial activity other than 
pterocellins H (188) and I (189). This indicates that the carbonyl group at position 
6 is important in the mechanism by which these compounds exert their 
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antibacterial activity.  The level of antitumour activity against the P388 cell line 
exhibited by the pterocellins would appear to be influenced by the size of the 
group at position 8 excluding pterocellins H (188) and I (189). Pterocellins A 
(108) and B (109) exhibit the strongest activity and they both have a hydrogen at 
position 8, pterocellin D (111), with an isopropyl group at this position, possesses 
intermediate activity and the other pterocellins C (110), E (112) and F (113) are 
essentially inactive in this assay and have larger groups at position 8. Pterocellins 
H (189) and I (189) also have a hydrogen at position 8 yet show no activity. This 
could be due to the propanoyl group hindering access to position 8 or 
alternatively, the carbonyl at position 6 could also be important for the antitumour 
activity. It is likely that the mechanism of action by which the pterocellins exhibit 
their antitumour activity is intercalation, so the bulkier the side chains, as in 
pterocellin C (110), or the more they deviate from the plane of the molecule, as 
the C6 sidechain does in pterocellins H (188) and I (189), the less likely the 
molecule is able to effectively intercalate into DNA. Antifungal activity appears 
to follow the same trend as antitumour activity, pterocellins A (108) and B (109) 
display good activity, pterocellin D (111) has intermediate activity and the 
remaining pterocellins that have been tested exhibit no activity in this assay. 
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2.5 Isolation and Structural Elucidation of 1-Methyl-5-bromo-8-
methoxy-β-carboline (190) 
 
2.5.1 Isolation of 1-Methyl-5-bromo-8-methoxy-β-carboline (190) 
TLC monitored separation of the extract of P. vesiculosa yielded a fraction 
containing the novel compound, 1-methyl-5-bromo-8-methoxy-β-carboline (190). 
The structure of 1-methyl-5-bromo-8-methoxy-β-carboline (190) was elucidated 
using HRESMS, 1D and 2D NMR experiments and X-ray crystallography. 
 
2.5.2 Characterisation of 1-Methyl-5-bromo-8-methoxy-β-carboline (190) 
The 1H NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-carboline (190) in 
CDCl3 (Figure 2.7) contained six resonances. Three signals represent aromatic 
protons, (a two proton singlet at 8.33 ppm and two mutually coupled doublets at 
7.25 ppm and 6.80 ppm). The spectrum also contained a methoxyl signal at 3.92 
ppm and a methyl signal at 2.77 ppm.   
 
The 13C NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-carboline (190) 
contained 13 signals, including six protonated carbon resonances (two aliphatic 
and four aromatic) and seven quaternary aromatic carbons.  
 
The HRESMS of compound (190) contained a [M+ H]+ pair of peaks at m/z 
291.0147 and 293.0049, an isotope pattern that indicated the presence of a 
halogen atom. The [M +Na]+ pair of peaks was also visible at m/z 312.9886 and 
314.9866. These peaks are consistent with a molecular formula C13H11N2OBr for 
compound (190).  
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Atom connectivity was established through NOESY, 1H-13C HMBC and 1H-13C 
HSQC NMR spectroscopic data. For example, in the HSQC NMR spectrum, the 
two coincidental aromatic protons at 8.33 ppm show correlations to two different 
carbon atoms, C3 and C4 (114.7 ppm and 139.0 ppm respectively). 
 
The NOESY NMR experiment showed correlations between the methoxyl group 
at 3.92 ppm and H7 at 6.80 ppm, and between H6 at 7.25 ppm and H7 at 6.80 
ppm. The methoxyl signal in the HMBC NMR experiment correlated to the 
quaternary carbon resonance of C8 (145.8 ppm). This confirmed that it is attached 
at position 8 as indicated in Figure 2.8.  
O
H3C
H
H
NOESY
O
H3C
H
H
HMBC
8
7
6 6
7
8
1010
 
 
Figure 2.8: NOESY and HMBC Correlations for a Structural Fragment of 
1-Methyl-5-bromo-8-methoxy-β-carboline (190) 
 
In the HMBC NMR experiment, the methyl proton resonance was correlated to 
C1, C4b and also showed a weak correlation to C3, indicating that it was attached 
at C1. The HRESMS information indicated the presence of a bromine atom and a 
combination of 1H NMR and NOESY spectroscopic experiments indicated that 
there was no proton at C5; therefore the bromine is attached at this position. Full 
HMBC NMR correlations can be seen in Figure 2.9.  
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Figure 2.9:  HMBC Correlations of 1-Methyl-5-bromo-8-methoxy-β-carboline 
(190). 
 
The NMR spectroscopic data was slightly ambiguous, so the structure of 
1-methyl-5-bromo-8-methoxy-β-carboline (190) was confirmed with the aid of an 
X-ray crystal structure solved by direct methods (Section 2.5.3). 
 
N
H
N
Br
O (190)  
 
The NMR spectroscopic data for 1-methyl-5-bromo-8-methoxy-β-carboline (190) 
is summarised in Table 2.4. 
Chapter 2 Studies of the Marine Bryozoan Pterocella vesiculosa 72 
Table 2.4: 1H and 13C NMR Spectroscopic Data for 1-Methyl-5-bromo-8-
methoxy-β-carboline (190) Recorded in CDCl3. 
 
 
N
H
N
Br
O
1
4 3
4a
4b
5
6
7
8
9a
9b
1'
10
(190)
 
 
Position 1H δ (ppm) (J, Hz) 13C δ (ppm)  HMBC (H to C) 
1     142.4   
3  8.33 s   114.7   1, 4, 4a,  
4  8.33 s   139.0   3, 4a, 4b, 9b 
4a     128.5 
4b     134.1 
5     108.1 
6  7.25 d (8.3)  123.6   5, 7, 8, 9b 
7  6.80 d (8.3)  109.0   5, 6, 8, 9a 
8     145.8 
9a     131.5 
9b     121.3 
10  3.92 s   55.6   8 
1’  2.77 s   20.4   1, 3, 4b 
 
 
The signals of H3 and H4 were coincidental although their chemical environments 
appear to be quite different. It has been seen previously in 5-bromo-β-carbolines 
that the H3 and H4 protons resonate closer together than is typical of any other 
β-carboline alkaloid. In the reported NMR spectroscopic data for eudistomin D 
(155) (5-bromo-6-hydroxy-β-carboline), the signals for H3 and H4 are at 8.55 
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ppm and 8.34 ppm respectively,118 for the acetylated derivative 5-bromo-6-
acetoxy-9-acetyl-β-carboline, the resonances for H3 and H4 were even closer 
together at 8.71 and 8.67 ppm respectively.118 This is in contrast to a β-carboline 
without a 5-bromo substituent such as harman (1-methyl-β-carboline) with H3 
and H4 resonances appearing at 8.43 and 7.83 ppm respectively.119 This data, 
along with the NMR data for (190) indicates that the presence of a bromine 
substituent at C5 on a β-carboline ring system has the effect of moving the 
resonances of H3 and H4 closer together. In the case of the new compound (190) 
they are coincidental.   
 
The addition of the 5-bromo and the 8-methoxyl groups to the base structure of 
1-methyl-β-carboline (harman) (97) results in the resonances of C5, C7, C8 and 
C9a shifting significantly as would be expected. In harman (97), the C5 resonance 
appears at 122.1 ppm,120 with the addition of a bromine at that point as in (190), 
the resonance shifts significantly upfield to 108.1 ppm. The 5-bromo substituent 
affects the chemical shift of C5 but has little effect on the neighbouring carbon 
atoms C6 and C9b. The addition of the methoxyl group at position 8 shifts the 
resonance of C8 from 111.9 as seen in harman (97)120 to 145.8 in 
1-methyl-5-bromo-8-methoxy-β-carboline (190). The addition of the methoxyl 
group also significantly affects the resonance of the neighbouring carbon atoms at 
C7 and C9b. C7 resonates at 128.5 ppm in harman (97),120 while in 1-methyl-5-
bromo-8-methoxy-β-carboline (190) it is shifted upfield to 109.0 ppm. The C9b 
signal appears in the 13C NMR spectrum of harman (97) at 140.5 ppm,120 but is 
shifted upfield to 131.5 ppm in 1-methyl-5-bromo-8-methoxy-β-carboline (190). 
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2.5.3 X-ray Crystal Structure of 1-Methyl-5-bromo-8-methoxy-β-carboline 
(190) 
 
Small block crystals were grown from toluene/heptane at room temperature over 
seven days. The unit cell dimensions and intensity data were obtained on a 
Bruker-Nonius Apex II CCD diffractometer. The structure was solved by direct 
methods using the SHELXS-97121 programme and Full matrix least-squares 
refinement was completed using the programme SHELXL-97.122 
 
The crystal was shown to have the formula C13H11N2OBr.CH3OH and was 
monoclinic with the space group P2(1)/c. There are four molecules in a unit cell. 
Crystal data and structural refinement detail are outlined in Table 2.5. Atomic 
coordinates and equivalent isotropic displacement parameters are presented in 
Table 2.6. Bond lengths and bond angles are displayed in Tables 2.7 and 2.8 
respectively. 
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Table 2.5: Crystal Data and Structure Refinement for 1-Methyl-5-bromo-8-  
methoxy-β-carboline (190). 
 
Empirical formula                  C14H15N2O2Br  
Formula weight                      323.19 
Temperature                         93(2) K 
Wavelength                          0.71073 Å  
Crystal system, space group        Monoclinic,  P2(1)/c 
Unit cell dimensions                a = 9.6025(5) Å    alpha = 90° 
                                         b = 10.9301(5) Å     beta = 107.645(2) ° 
                                          c = 13.3928(6) Å    gamma = 90° 
Volume                              1339.53(11) Å3
Z, Calculated density               4, 1.603 mg/m3
Absorption coefficient             3.068 mm-1
F(000)                              656 
Crystal size                        0.60 x 0.56 x 0.30 mm 
Theta range for data collection    2.90  < θ < 28.00° 
Limiting indices                    -12 <= h <= 8, -13 <= k <= 14, 
-15 <= l <= 17 
Reflections collected / unique     11505 / 3236 [R(int) = 0.0382] 
Completeness to θ = 28.00      99.9 % 
Absorption correction              Semi-empirical 
Max. and min. transmission         0.4596 and 0.2604 
Refinement method                  Full-matrix least-squares on F2 
 
Data / restraints / parameters     3236 / 0 / 199 
Goodness-of-fit on F2              1.074 
Final R indices [I > 2sigma(I)]      R1 = 0.0316, wR2 = 0.0827 
R indices (all data)                R1 = 0.0364, wR2 = 0.0848 
Largest diff. peak and hole        1.212 and -0.448 e. Å-3
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Table 2.6: Atomic Coordinates (x 104) and Equivalent Isotropic Displacement 
Parameters (Å2 x 103) for 1-Methyl-5-bromo-8-methoxy-β-carboline (190). 
(U(eq) is defined as one third of the trace of the orthogonalized Uij tensor). 
  
Atom                  x       y         z   U(eq)                            
Br (1)         7292 (1) 983 (1) 1311 (1) 32 (1) 
O (1)  9883 (2) -3364 (1) -332 (1) 23 (1) 
N (1)  13724 (2) 710 (2) 2872 (1) 22 (1) 
N (2)         11616 (2) -1691 (2) 1139 (1) 17 (1) 
C (1)         13505 (2) -331 (2) 2319 (1) 20 (1) 
C (3)         12559 (2) 1386 (2) 2910 (2) 24 (1) 
C (4)         11119 (2) 1088 (2) 2406 (2) 21 (1) 
C (4a)         10853 (2) 13 (2) 1803 (1) 17 (1) 
C (4b)        12076 (2) -690 (2) 1776 (1) 17 (1) 
C (5)          8070 (2) -396 (2) 799 (2) 21 (1) 
C (6)          7150 (2) -1175 (2)  95 (2) 23 (1) 
C (7)          7709 (2) -2198 (2) -302 (2) 21 (1) 
C (8)         9195 (2) -2439 (2) 11 (1) 18 (1) 
C (9a)        10118 (2) -1642 (2) 739 (1) 16 (1) 
C (9b)          9581 (2) -604 (2) 1137 (1) 18 (1) 
C (10)         9001 (2) -4161 (2) -1121 (2) 25 (1) 
C (1’)        14797 (2) -1084 (2) 2291 (2) 27 (1) 
O (Methanol)      3521 (2) 6457 (1) 859 (1) 27 (1) 
C (Methanol)      3419 (3) 5987 (2) -148 (2) 28 (1) 
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Table 2.7: Bond Lengths (Å) from X-ray Crystal Data for 1-Methyl-5-bromo-8-
methoxy-β-carboline (190). 
 
Bond (Å) Bond (Å) 
Br(1)-C(5)         1.8998 (19) C(4)-C(4a)            1.405 (3) 
O(1)-C(8)          1.361 (2) C(4)-H(4)             0.93 (2) 
O(1)-C(10)        1.432 (2) C(4a)-C(4b)          1.414 (3) 
N(1)-C(1)          1.339 (2) C(4a)-C(9b)          1.443 (3) 
N(1)-C(3)          1.354 (3) C(9b)-C(5)            1.402 (3) 
N(2)-C(4b)        1.375 (2) C(9b)-C(9a)          1.415 (3) 
N(2)-C(9a)         1.375 (2) C(5)-C(6)              1.375 (3) 
N(2)-H(1)          0.75 (3) C(6)-C(7)              1.412 (3) 
C(1)-C(4b)         1.400 (3) C(6)-H(6)             0.92 (3) 
C(1)-C(1’)         1.499 (3) C(7)-C(8)             1.385 (3) 
C(3)-C(4)           1.381 (3) C(7)-H(7)             1.00 (2) 
C(3)-H(3)          0.98 (2) C(8)-C(9a)            1.404 (2) 
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Table 2.8: Bond Angles (°) from X-ray Crystal Data for 1-Methyl-5-bromo-8-
methoxy-β-carboline (190). 
 
Angle (°) Angle      (°) 
C(8)-O(1)-C(10)    117.52 (15) C(9a)-C(9b)-C(4a)   105.74 (16) 
C(1)-N(1)-C(2)     119.45 (17) C(6)-C(5)-C(9b)     120.58 (18) 
C(4b)-N(2)-C(9a)   108.22 (16) C(6)-C(5)-Br(1)      119.85 (15) 
C(4b)-N(2)-H(1)    129.00 (2) C(9b)-C(5)-Br(1)     119.57 (14) 
C(9a)-N(2)-H(1)    123.00 (2) C(5)-C(6)-C(7)      120.64 (18) 
N(1)-C(1)-C(4b)    119.37 (18) C(5)-C(6)-H(6)      120.30 (16) 
N(1)-C(1)-C(1’)    119.23 (17) C(7)-C(6)-H(6)      119.10 (16) 
C(4b)-C(1)-C(1’)   121.40 (17) C(8)-C(7)-C(6)      120.74 (18) 
N(1)-C(3)-C(4)     124.67 (18) C(8)-C(7)-H(7)      120.60 (13) 
N(1)-C(2)-H(2)     116.30 (13) C(6)-C(7)-H(7)      118.70 (13) 
C(3)-C(2)-H(2)     118.90 (13) O(1)-C(8)-C(7)      126.85 (17) 
C(3)-C(4)-C(4a)    117.32 (19) O(1)-C(8)-C(9a)     115.25 (16) 
C(3)-C(4)-H(4)     120.00 (15) C(7)-C(8)-C(9a)     117.87 (17) 
C(4a)-C(4)-H(4)    122.70 (15) N(2)-C(9a)-C(8)     127.71 (17) 
C(4)-C(4a)-C(4b)   117.54 (17) N(2)-C(9a)-C(9b)    109.96 (16) 
C(4)-C(4a)-C(9b)   135.97 (18) C(8)-C(9a)-C(9b)    122.28 (17) 
C(4b)-C(4a)-C(9b)  106.47 (16) N(2)-C(4b)-C(1)     128.75 (17) 
C(5)-C(9b)-C(9a)   117.87 (17) N(2)-C(4b)-C(4a) 109.59 (16) 
C(5)-C(9b)-C(4a)   136.35 (17) C(1)-C(4b)-C(4a)    121.64 (17) 
 
 
Figure 2.10 shows an Oak Ridge thermal ellipsoid plot (ORTEP) representation of 
1-methyl-5-bromo-8-methoxy-β-carboline (190). 
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Figure 2.10: ORTEP Projection of 1-Methyl-5-bromo-8-methoxy-β-carboline 
(190). 
 
The packing in 1-methyl-5-bromo-8-methoxy-β-carboline (190) is such that a 
molecule is reflected then moved up half a molecule. Hydrogen bonding occurs 
between the oxygen on a methanol molecule and the pyridol hydrogen of this 
compound and also between the hydroxyl hydrogen of that same methanol 
molecule with the tertiary nitrogen of another 1-methyl-5-bromo-8-methoxy-β-
carboline molecule. This helps to stack and align the molecules in the crystal. A 
diagram of the stacking and another of the hydrogen bonding of (190) are 
presented in Figures 2.11 and 2.12 respectively. 
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Figure 2.11:  Stacking of 1-Methyl-5-bromo-8-methoxy-β-carboline (190) within 
the Unit Cell. 
 
 
Figure 2.12: Hydrogen Bonding Interactions of 1-Methyl-5-bromo-8-methoxy-β-
carboline (190) with Methanol within the Crystal Structure. 
 
Crystal structure data indicated that 1-methyl-5-bromo-8-methoxy-β-carboline 
(190) is planar throughout other than the methoxyl sidechain, which deviates from 
the molecular plane. In general, the bond lengths and angles are as would be 
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expected for a molecule with this structure. The bond length C(6)-C(7) is longer 
than the median length for this type of system and the bond angle O(1)-C(8)-C(7) 
is slightly smaller than the median for that angle, although both fit within 
previously observed limits. 
 
2.6 Biological Evaluation of Selected β-Carboline Alkaloids. 
β-Carboline alkaloids have been found from the family Catenicellidae to which P. 
vesiculosa belongs, although this is the first example of a β-carboline alkaloid in 
the genus Pterocella. Previous work on Costaticella hastata and Cribricellina 
cribraria, has led to the isolation of β-carboline alkaloids. These alkaloids only 
show significant activity in the P388 biological assay when there is a vinyl group 
present at C1. Pavettine (1-vinyl-β-carboline) (100) has an IC50 value of 100 
ng/mL whereas harman (1-methyl-β-carboline) (97) is virtually inactive with an 
IC50 value of >12500.81 Table 2.9 presents the activity of some relevant 
β-carboline alkaloids including the new compound (151) in the P388 antitumour 
assay. Other β-carboline alkaloids show different types of biological activity. The 
results are not directly comparable due to the use of different assay systems but 
they are discussed below. 
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Table 2.9: Activity o f Selected β-Carboline Alkaloids in the P388 Antitumour 
Assay.81,119 
 
Alkaloid                 P388   
       IC50 (ng/mL) 
 
1-Methyl-β-carboline (95)    >12500 
1-Methyl-5-bromo-8-methoxy-β-carboline (190)          5089   
1-Methyl-6-hydroxy-β-carboline (99)  >12500 
1-Methyl-8-hydroxy-β-carboline (100)  >12500 
1-Vinyl-β-carboline (98)          100  
1-Vinyl-8-hydroxy-β-carboline (101)        100 
1-Vinyl-8-methoxy-β-carboline (191)        100  
1-Vinyl-8-acetoxy-β-carboline (192)         650  
1-Ethyl-β-carboline (96)    >12500 
1-Ethyl-4-methylsulfone-β-carboline (102)  >12500 
1-Ethyl-8-hydroxy-β-carboline (193)   >12500 
1-Ethyl-8-methoxy-β-carboline (194)  >12500 
1-Propyl-β-carboline (195)    >12500 
 
β-Carbolines with a vinyl substituent at C1 have strong activity in this assay, 
while the other compounds are essentially inactive except for 1-methyl-5-bromo-
8-methoxy-β-carboline (190) which has intermediate activity. This suggests the 
bromine substituent is influencing the mechanism by which β-carboline alkaloids 
exert their inhibitory activity on the P388 cells. 
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Investigation into the cytotoxicity of the β-carboline alkaloid harmine (1-methyl-
7-methoxy-β-carboline) (196) and its analogues (197-200) across a range of 
assays representative of different cancer types including an epidermoid carcinoma 
(KB), a lung carcinoma (A549), renal cancer (CAKI-1), breast cancer (MCF-7), 
ovarian cancer (1A9), a glioblastoma (U-87-MG), and a melanoma cancer (SK-
MEL-2) allowed structure-activity relationships to be established.123  
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The 6-bromo analogue (200) of harmine (196) shows decreased activity across 
this range of antitumour assays but it shows increased activity against the 
glioblastoma cell line U-87-MG with an ED50 of 7.8 μg/mL compared with the 
ED50 of harmine (196) at 14.5 μg/mL.123 This indicated the bromination of 
harmine causes the compound to become more selective and increasingly toxic to 
this cell line whilst decreasing its activity against all other cell lines tested. 
Analogues of harmine with hydroxyl (197) or acetoxyl (198) substituents instead 
of a methoxyl group at C7 generally display decreased activity but are selectively 
more active against the MCF-7 breast cancer cell line. The ED50 of harmine (196) 
against MCF-7 is 10.5 μg/mL whereas the C7 hydroxyl analogue (197) has an 
ED50 of 9.2 μg/mL and the C7 acetoxyl analogue (198) has an ED50 of 5.0 
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μg/mL.123 Harmine (196) displays better activity across the whole range of assay 
cell lines tested than its C7 demethoxyl equivalent harman (97).123 
 
The strength of the antimicrobial activity of β-carboline alkaloids varies 
significantly depending on the substituents. 1-Methyl-5-bromo-8-methoxy-β-
carboline (190) displayed inhibitory action towards B. subtilis, C. albicans and T. 
mentagrophytes with MID ranges of 2-4, 4-5 and 4-5 μg/mL respectively. Against 
the same three microorganisms 1-methyl-β-carboline (97) has MID values of 7.5-
15, 1.9-3.8 and 3.7-7.5 μg/mL respectively, 1-ethyl-8-methoxy-β-carboline (194) 
has MID values of >60, 7.5-15 and 7.5-15 μg/mL respectively and 1-ethyl-8-
hydroxy-β-carboline (193) has an MID of 30-60 μg/mL for all three. This data 
indicates that the ethyl group at the C1 position decreases the potency of the β-
carboline across the range of microorganisms, it also indicates that the 5-bromo 
and/or 8-methoxyl substituents increases the potency of the β-carboline toward B. 
subtilis while decreasing the potency against C. albicans and has little effect on 
the potency against T. mentagrophytes. 1-Vinyl-β-carboline (98) has MID ranges 
of 1.9-3.8, 1.9-3.8 and 0.1-0.2 μg/mL against the three previously mentioned 
microorganisms respectively while the 8-methoxyl analogue (191) had MID 
ranges of 7.5-15, 15-30 and 0.45-0.9 μg/mL respectively. This indicates that the 
8-methoxy substituent decreases the potency of the β-carboline across this range 
of microorganisms, which could indicate the bromo substituent in (190) is 
responsible for the increased activity compared to that of (97) against B. subtilis. 
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2.7 Further work 
Thin layer chromatography (TLC) analysis of the crude extract of this sample of 
P. vesiculosa indicated the presence of a number of coloured compounds not 
previously observed in studies of this organism implying that there are potentially 
more novel compounds that could be isolated from this extract. Mass spectral 
evidence indicated the presence of additional β-carboline alkaloids in this extract. 
The data indicated the demethoxyl and debromo analogues of 1-methyl-5-bromo-
8-methoxy-β-carboline (190) were present. Further investigation needs to be 
carried out to isolate and fully characterise these compounds. If these prove to be 
1-methyl-5-bromo-β-carboline and 1-methyl-8-methoxy-β-carboline respectively, 
the former would be a new compound. 
 
UV data and optical rotation experiments are still to be carried out on the new 
compounds pterocellins H (188) and I (189). Pterocellins H (188) and I (189) also 
need to be isolated in larger quantities so that derivatisation of the 6-hydroxyl 
group can be performed and structure-activity relationships can be investigated.  
 
Larger quantities of pterocellin G (114) still need to be isolated in order for 
biological evaluation and other analytical experiments to be completed. 
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Chapter Three 
Chemical Survey of New Zealand Marine Organisms 
 
3.1 Introduction 
A survey of eighty-five marine samples collected from three different sites around 
the upper North Island of New Zealand was carried out. This involved extracting a 
sub-sample of each specimen and testing the crude extract in a variety of assays. 
A portion of each crude extract was subject to analysis by liquid chromatography 
mass spectrometry (LCMS) equipped with a photodiode array (PDA) detector and 
mass spectrometer, as well as thin layer chromatography (TLC).  
 
3.2 Biological Survey 
The crude extracts of all samples in the survey were tested in the biological assays 
run at the University of Canterbury (see Section 1.4). 
 
The bioassay results showed that twelve samples had significant activity against 
the P388 tumour cell line. Eight of those samples also showed slight antimicrobial 
activity. Of those eight, three were active in the antiviral assay as well. There was 
no activity seen in either assay of Gram-negative bacteria (P. aeruginosa and E. 
coli) and also no activity against the fungus C. resinae. Most samples showed 
either no activity or limited activity in the antimicrobial assays. Full biological 
assay results are presented in Appendix Four. 
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3.3 Chemical Survey 
As part of the chemical survey, samples were analysed by LCMS with a PDA 
detector scanning wavelengths from 190 to 800 nm, as well as a MS detector 
scanning m/z range 150 to 1400. This allowed inspection of the UV spectra for 
individual chromatographic peaks, as well as the equivalent mass spectrum. 
LCMS was the technique chosen instead of HPLC for this reason. 
 
The LCMS analysis produced a lot of data about the contents of the crude 
extracts. The MS chromatograms were difficult to analyse in the area between 
roughly 10 and 24 minutes as the spectra produced during these periods are 
swamped with large clusters of peaks between m/z 150-200, probably as a result 
of solvent mixing. Anything that elutes during this time does not have a suitable 
mass spectrum to accompany the PDA spectrum unless it has a mass spectral peak 
above the area where the peak clusters occur with significant intensity.  
 
Seventeen samples in the collection were preliminarily identified as Pterocella 
vesiculosa. The samples were collected from the Alderman Islands and White 
Island. On chemical investigation it was clear that one of these samples was not P. 
vesiculosa. This sample (05-TS1-01) displayed no similarities in its TLC spotting 
patterns or LCMS chromatogram to the other samples. The spotting pattern on 
TLC plates was very similar throughout the other sixteen samples. Analyses of the 
LCMS chromatograms (both PDA and MS) showed that the chemical 
compositions of these samples were reasonably similar. A combination of the 
PDA UV spectrum and the mass spectral information indicated that the 
chromatographic peak at a retention time of 25.7 minutes in sample 05-HC1-01 is 
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pterocellin A (108), while the closely related peak at retention time 26.5 minutes 
appears to be pterocellin B (109). A representative chromatogram for this group 
of samples is presented in Figure 3.1. The analogous peaks appear in all of the 
chromatograms of the above samples. Both compounds have been previously 
isolated from P. vesiculosa but not reported from any other source, therefore this 
is good evidence that all of these sixteen samples are indeed P. vesiculosa.  
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Figure 3.1: A Chromatogram of Sample 05-HC1-01 with UV traces, 
Representative of the P. vesiculosa Samples. 
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The biological activity of these samples varies significantly. Only three samples 
showed activity against the P388 tumour cell line, 05-HR1-02, 05-SA1-06 and 05-
TT1-03 (IC50 values of 82403, 75361 and 92827 ng/mL respectively). 
Antimicrobial assay results showed that the majority of samples have activity 
against B. subtilis. There is correlation between the collection location of the 
sample and the strength of its crude extract activity, with the samples that had the 
strongest effect being those from the White Island collection.  Tables 3.1 and 3.2 
show complete biological assay results for the P. vesiculosa samples. 
 
Table 3.1: Antitumour and Antimicrobial Assay Results for P. vesiculosa 
Samples.a 
 
 Antitumour Anti-microbial 
Sample 
P388 
 
(IC50 μg/mL) 
B. subtilis 
inhibition zone 
(mm) 
05-TS1-02 > 125000 1 
05-TT1-01 > 125000 0 
05-TT1-02 > 125000 2 
05-TT1-03 92827 1 
05-TT1-04 > 125000 1 
05-MC1-02 > 125000 1 
05-MC1-03 > 125000 1 
05-MC1-04 > 125000 1 
05-MC1-05 > 125000 1 
05-OB1-01 > 125000 1 
05-OB1-02 > 125000 2 
05-HC1-01 > 125000 2 
05-HC1-02 > 125000 2 
05-HC1-03 > 125000 2 
05-HR1-02 82403 3 
05-SA1-06 75361 3 
a Refer to Section 1.4 for details of assay.
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Table 3.2: Antiviral/Cytotoxicity Assay Results for P. vesiculosa Samples.a 
 
 Antiviral/Cytotoxicity Assay 
Sample HSV HCyt PV1 PCyt 
05-TS1-02 ND ND ND ND 
05-TT1-01 ND ND ND ND 
05-TT1-02 ND ND ND ND 
05-TT1-03 ?* 2+ ND ND 
05-TT1-04 ND ND ND ND 
05-MC1-02 ND ND ND ND 
05-MC1-03 ND ND ND ND 
05-MC1-04 ND ND ND ND 
05-MC1-05 ND ND ND ND 
05-OB1-01 ND ND ND ND 
05-OB1-02 ND ND 3+ +*,7 
05-HC1-01 ND ND ND ND 
05-HC1-02 ND ND ND ND 
05-HC1-03 ND ND ND ND 
05-HR1-02 ND ND ND ND 
05-SA1-06 ND ND ND ND 
a
 Refer to section 1.4  for details of assay. Tables 1.1 and 1.2 have an explanation of the results. 
 
Samples 05-DP1-03 and 05-DP1-04 were both identified as being the sponge, 
Raspailia sp. The samples were both collected from Devil’s Point in the Mercury 
Islands and showed similar spots on TLC plates, although the intensity of the 
spots differed in some cases. Furthermore, comparison of their LCMS 
chromatograms and UV and MS profiles indicated that the chemical composition 
of the two samples is reasonably similar. For example, the UV spectrum of the 
chromatographic peak at retention time 30.39 minutes of sample 05-DP1-03 is 
very similar to the analogous peak of sample 05-DP1-04, although the 
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chromatogram of sample 05-DP1-04 had more peaks compared with that of 
05-DP1-03. Sample 05-DP1-04 showed activity against the P388 cell line (IC50 
value of 77639 ng/mL) whereas 05-DP1-03 was inactive. Both samples had 
inhibitory activity in the antimicrobial assay against the fungus T. mentagrophytes 
(3 mm inhibition zone for both). Neither showed any activity in the antiviral 
cytotoxicity assay. 
 
Four samples were thought to be the sponge Polymastia sp., 05-OI1-08, 
05-DP1-02, 05-DP1-08 and 05-SA1-12. All samples were inactive in the 
antitumour and antiviral/cytotoxicity assays but had very different activities in the 
antimicrobial assay. Sample 05-OI1-08 was inactive, 05-DP1-02 and 05-DP1-08 
showed antimicrobial activity against T. mentagrophytes (3 mm and 1 mm 
inhibition zones respectively), while 05-SA1-12 showed antimicrobial activity 
against C. albicans (3 mm inhibition zone). The TLC chromatograms for these 
four samples revealed similar contents with 05-OI1-08 and 05-SA1-12 having 
additional compounds in their respective traces unique to that sample. The LCMS 
chromatograms of samples 05-OI1-08, 05-DP1-02, 05-DP1-08 showed strong 
similarities, especially in the cluster of peaks between retention times of 23.50 and 
26.00 minutes. The LCMS data indicates that these three samples contain at least 
some of the same metabolites. The chromatogram of sample 05-SA1-12 was 
different to that of the other three. 
 
The survey collection included five algal species (05-DP1-05, 05-HR1-03, 
05-SA1-08, 05-MC1-06 and 05-HC1-04). Three of these, 05-HR1-03, 05-SA1-08 
and 05-MC1-06 were red, feathery algal species, 05-DP1-05 was a pink coralline 
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algal species and 05-HC1-04 was a dark red alga. The TLC spotting patterns of 
these five samples were quite different, although there were two spots that were 
consistent across all five samples, which could represent common primary 
metabolites. The LCMS trace of all five samples was very simple indicating that 
these samples contain fewer compounds than most other samples or that the 
chromatographic separation is not optimised to separate the compounds contained 
in these samples. There was no biological activity exhibited by any of these 
samples. 
 
Eight samples were hydroids (05-HR1-04, 05-HR1-05, 05-HR1-06, 05-HR1-08, 
05-HR1-09, 05-HR1-10, 05-SA1-04 and 05-TT1-05). These samples differed in 
colour, 05-HR1-04 was white, 05-HR1-05 was yellow, 05-HR1-06 and 
05-HR1-09 were brown, 05-HR1-08 and 05-TT1-05 were orange, 05-HR1-10 was 
green and 05-SA1-04 appeared to be a mixture of hydroids. Five of the hydroid 
samples showed no biological activity, sample 05-HR1-06 showed significant 
inhibitory activity against the P388 tumour cell line (IC50 value of 65196 ng/mL), 
sample 05-SA1-04 showed slight activity in the same assay (IC50 value of 121357 
ng/mL) and sample 05-TT1-05 showed marginal activity in the 
antiviral/cytotoxicity assay against the Polio virus strain with the virus growing 
right up to the cytotoxic zone which extended 1-2 mm radius from the edge of the 
disk. TLC analysis supported these samples being different species as all samples 
gave very different spotting patterns. The LCMS chromatograms were also very 
different; there seemed to be no consistency across this group in either the number 
of peaks in the chromatogram or the retention times of any of the peaks. 
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Samples 05-OI1-10, 05-OI1-11 and 05-OI1-12 were all identified as being the 
bryozoan Bugula dentata. The samples were collected from Ohinau Island in the 
Mercury Islands and gave similar spots on the TLC plates, although sample 05-
OI1-11 had fewer spots than the other two samples. Comparison of the LCMS 
chromatograms and UV and MS profiles of the three samples indicated that the 
chemical composition is reasonably similar again with sample 05-OI1-11 having 
fewer peaks than the others. There appeared to be a series of compounds common 
to all three samples. The compounds had no obvious chromophore but showed 
strong peaks in the mass spectral chromatogram, these compounds had m/z values 
of 312.7, 340.9, 519.3 and 547.7, with retention times ranging from 36 to 42 
minutes. Sample 05-OI1-12 contained an extra compound with an m/z of 326.8 
not apparent in the other two samples. All three samples showed inhibitory 
activity against the P388 cell line, with IC50 values of 114341 ng/mL, 110986 
ng/mL and 61181 ng/mL respectively. Clearly sample 05-OI1-12 was 
significantly more active than the other two. Sample 05-OI1-12 was the only 
sample to show activity in the antimicrobial assay (1 mm inhibition zone against 
T. mentagrophytes). No activity was seen in the antiviral/cytotoxicity assay. 
 
There were five samples that appeared to be Steginoporella neozelanica (05-HR1-
11, 05-TS1-04, 05-MC1-01, 05-OB1-03 and 05-HC1-05). Samples 05-TS1-04 
and 05-OB1-03 showed slight activity against the P388 cell line in the antitumour 
assay (121357 and 117797 ng/mL respectively).  Sample 05-MC1-01 was the only 
one of these samples to show activity in the antimicrobial (1 mm inhibition zone 
against B. subtilis) and antiviral/cytotoxic bioassays with activity against both 
Herpes simplex type 1 virus and Polio virus type 1. The TLC traces of these 
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samples are essentially identical, other than additional spots were seen under UV 
light in the trace of sample 05-MC1-01. The LCMS chromatogram varied across 
these samples. They all had a similar group of peaks between retention times of 
8.30-9.50 minutes. The chromatogram of sample 05-TS1-04 contained a lot more 
peaks than the other chromatograms. These peaks were typically small and had 
retention times between 22 and 30 minutes. 
 
Six samples were identified as the soft coral Alcyonium species (05-OI1-09, 
05-DP1-12, 05-DP1-13, 05-DP1-15, 05-DP1-18 and 05-SA1-05). Samples 
05-OI1-09, 05-DP1-12 and 05-DP1-13 appear to have very similar spotting 
patterns. The other three samples had unique spotting patterns, with no correlation 
between them or with the patterns of the first three samples. Unexpectedly there 
were no obvious similarities between any of the chromatograms for these six 
species. 
 
The biological activity of these samples varied, with samples 05-OI1-09, 
05-DP1-18 and 05-SA1-05 showing activity in the P388 assay (IC50 values of 
114341, 68920 and 121357 ng/mL respectively), while samples 05-OI1-09, 
05-DP1-12 and 05-DP1-13 all showed activity in the antiviral/cytotoxicity assay 
although the antiviral activity was indeterminable due to the strong cytotoxicity in 
all three samples against both virus types.  
 
Samples 05-OI1-01, 05-OI1-06, 05-OI1-07 and 05-OI1-13 appeared to be the 
same species of red encrusting sponge. All samples showed no biological activity 
except 05-OI1-13, which showed limited activity in the antimicrobial assay 
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against the fungus T. mentagrophytes (1 mm inhibition zone). Samples 
05-OI1-01, 05-OI1-06 and 05-OI1-07 had very similar TLC spotting patterns. 
TLC analysis indicated sample 05-OI1-13 had less compounds present in its crude 
extract than the other three samples.  
 
LCMS analysis showed samples 05-OI1-01 and 05-OI-06 contained many of the 
same compounds. Comparisons of the peaks in the chromatogram of 05-OI1-01 at 
27.7, 31.86, 33.40, 35.94, 40.85 and 42.56 minutes with the analogous peaks in 
the chromatogram of 05-OI1-06 were similar. Sample 05-OI1-07 did not appear to 
contain these peaks, while sample 05-OI1-13 contained peaks analogous to those 
from sample 05-OI1-01 at 33.40, 35.94, 40.85 and 42.56 minutes. 
 
Five brown samples identified as being bryozoans appeared similar (05-TS1-03, 
05-HC1-06, 05-HC1-07, 05-OB1-06 and 05-OB1-07). TLC analysis showed 
samples 05-TS1-03, 05-HC1-06 and 05-HC1-07 had the same TLC spotting 
patterns. Samples 05-OB1-06 and 05-OB1-07 had fewer spots than the other three 
samples, while 05-OB1-06 had an additional spot visible under UV light at 254 
nm that was unique to that sample. The LCMS chromatogram of sample 
05-OB1-06 was very simple, with the only distinguishing feature, a strong peak at 
a retention time of 25.01 minutes. Samples 05-HC1-06, 05-HC1-07 and 
05-OB1-07 all had similar chromatograms with minimal distinguishable peaks 
other than the strong peak analogous to the one seen in the chromatogram of 
05-OB1-06. Sample 05-TS1-03 produced a chromatogram that along with this 
analogous peak contained a lot more peaks. None of these samples showed 
activity in any of the biological assays. 
Chapter 4 Studies of Two Marine Organisms 98 
Chapter Four 
Studies of Two Marine Organisms 
 
4.1 Introduction 
Results from the survey (work described in Chapter Three) indicated which 
samples exhibited cytotoxicity toward the P388 cell line. Of the active samples, 
two were identified as promising leads for further investigation. The crude 
extracts of samples 05-OI1-02 and 05-SA1-10 showed strong inhibition in the 
P388 antitumour assay with IC50 values of 39141 and 52717 ng/mL respectively. 
The other samples that showed activity in the P388 assay were either samples of 
P. vesiculosa or showed weaker inhibition.  
 
4.2 Studies of a Sponge from the Family Darwinellidae  
4.2.1 Bioactivity Directed Separation 
The crude methanol/dichloromethane extract taken from a sponge belonging to 
the family Darwinellidae, from the 2005 collection at the Spanish Arch, White 
Island showed activity against the P388 murine leukaemia cell line and also slight 
antibacterial activity against B. subtilis. Separation of the crude extract by 
reversed phase column chromatography resulted in one active fraction (IC50 of 
1522 ng/mL). Size exclusion chromatography was performed on the active 
fraction, resulting in the activity concentrating into two consecutive fractions with 
IC50 values of 751 and 508 ng/mL respectively. No spots were observed on the 
TLC plate in visible light or under UV light. Analysis by high resolution 
electrospray mass spectrometry (HRESMS) indicated that there was a complex 
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mixture present; 1H NMR spectroscopic experiments also supported the presence 
of a complex mixture. The NMR spectroscopic data on these two fractions was 
very similar indicating that they contained the same mixture. 
 
The 1H NMR spectrum of these fractions in CDCl3 (Figure 4.1) showed a number 
of clearly defined signals downfield of 3 ppm. The signals varied in intensity 
indicating that there was a mixture of compounds in the fraction. The region 
upfield from 3 ppm was ambiguous, it contained multiple signals overlapping 
which were unable to be differentiated from each other and separate multiplicity 
was impossible to determine. The COSY NMR spectrum contained a lot of 
correlations, most of which would correlate to at least one undeterminable signal 
upfield of 3 ppm. The HMBC NMR spectrum again was not helpful in elucidation 
of the structure of these compounds. It did contain a lot of variation in signal 
intensity adding to the evidence for a mixture of compounds, possibly a series of 
compounds. The HMBC NMR spectrum contained strong signals with weaker 
signals in close vicinity to them, indicating another molecule with the same sub-
structure but with NMR signals that were slightly altered in their shift due to 
changes elsewhere in the molecule.  
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The two active fractions were combined and subjected to further size exclusion 
chromatography. The resulting fractions were analysed by HRESMS and also 
NMR spectroscopy, which indicated that the mixture of active compounds 
co-eluted from the column over several fractions.  The separation tree for this 
fraction is presented in Appendix Five. 
 
Due to the complex spectra obtained from this mixture, no definite structural 
elucidation could be carried out. The mixture was unable to be separated further 
due to insufficient quantities and a further collection of the sponge was deemed 
impractical. Taxonomic information and spectral data were used to identify 
possible compounds in the mixture from the literature.  
 
Within the order Dendroceratida, family Darwinellidae, the genera of Dendrilla or 
Chelonaplysilla have been shown to produce many novel diterpenes (some 
occurring in species of both genera), with varying biological activity. 
 
The diterpenoids dendrillols 1-4 (201-204) as well as the aplyroseols 1-6 (205-
210) were extracted from a sample of Dendrilla rosea collected from New 
Zealand. No biological activity was reported for these compounds. Structural 
elucidation resulted from NMR spectroscopic and MS data as well as X-ray 
crystallographic data.124 
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A series of compounds dendrillolides A (211), B and C – E (212-214) have been 
isolated from a Dendrilla sp.125 Dendrillolides A (211) and D (213) were isolated 
from a sample preliminarily identified as a Dendrilla species then later 
reidentified as a Chelonaplysilla species.126 The structure of dendrillolide B 
remains undetermined. 
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The Antarctic sponge Dendrilla membranosa has yielded novel diterpenes 
membranolides A-D (215-218).127,128 Membranolide A (215) inhibited the growth 
of B. subtilis at 100 μg/disk and was also mildly active against S. aureus.127 
Membranolides C (217) and D (218) also display antibacterial and antifungal 
activity.128 
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Three new diterpenoid metabolites, chelodane (219), barekoxide (220) and 
zaatirin (221), were isolated from the cytotoxic extract of Chelonaplysilla erecta. 
Structures were determined predominantly by 1D and 2D NMR spectroscopy. 
These compounds were not responsible for the cytotoxicity of the crude extract.129 
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4.2.2 Sterols from a Sponge of the Family Darwinellidae 
Three non-polar fractions from the initial reversed phase column on the crude 
extract of the Darwinellidae species contained sterols as indicated by TLC 
analysis. These fractions were purified by normal phase column chromatography 
to yield fractions containing relatively pure sterols, which were derivatised to 
form the trimethylsilyl (TMS) ethers. The mixture of TMS ethers was subject to 
separation and analysis by gas chromatography mass spectrometry (GCMS). They 
were identified by comparison of fragmentation patterns with literature 
values.130-134 The composition percentage was determined based on peak area with 
the assumption that all sterols had the same response factor. The sterol 
composition of this sponge is shown in Table 4.1. 
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Table 4.1: Sterol Composition of a Sponge from the Darwinellidae Family. 
 
Sterol      Structure Composition (%) 
(22Z)-Cholest-22-en-3β-ol 222a 56.2
Cholesterol 223b 10.2
24-Methylcholest-5,22-dien-3β-ol 223c 7.5
Cholest-5,22-dien-3β-ol 223d 6.4
24-Ethylcholest-5-en-3β-ol 223e 6.4
24-Methylcholest-5,24(28)-dien-3β-ol 223f 2.0
24-Ethylcholest-5,24(28)-dien-3β-ol 223g 1.7
24-Methylcholest-7-en-3β-ol 224h 1.3
Cholestanol 222b 1.2
24-Methylcholest-22-en-3β-ol 222i 1.0
Unidentified 6.1
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4.3 Studies of an Unidentified Marine Organism 
4.3.1 Bioactivity Directed Separation 
The methanol/dichloromethane crude extract of an unidentified, dark blue, 
amorphous sample collected from Ohinau Island in the Mercury Islands in 2005, 
displayed strong activity against the P388 murine leukaemia cell line with an IC50 
of 39141 ng/mL as well as moderate antibacterial activity against B. subtilis, C. 
albicans and T. mentagrophytes, so was chosen for further investigation. Attempts 
at identifying this marine organism were unsuccessful. 
 
The crude extract was subjected to reversed phase column chromatography. The 
activity spread across six fractions but was clearly concentrated into two of these. 
The two most active fractions, which had IC50 values of 3032 and 4215 ng/mL, 
were combined and subject to size exclusion chromatography which concentrated 
the activity in two fractions. These fractions were subjected to TLC, HRESMS 
and NMR spectroscopic analysis, the results of which indicated the presence of a 
mixture of compounds. 1H NMR experiments showed little, due to the spectra 
being swamped with a peak indicative of ‘grease’. The fractions were combined 
and attempts made to remove the grease, however they were unsuccessful. The 
combined fractions were subjected to a further size exclusion column. Biological 
assay indicated the activity had spread across six fractions. HRESMS analysis of 
these fractions revealed a mixture of compounds. 1H NMR data was unhelpful as 
it showed the large grease signal and little else. Due to the activity spreading, 
insufficient quantities and lack of taxonomic information, no further investigation 
of this species was pursued. The separation tree for this organism is displayed in 
Appendix Five. 
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4.3.2 Sterols Identified from the Unidentified Marine Organism 
TLC analysis revealed the presence of sterols in two non-polar fractions from the 
initial reversed phase column on the crude extract. These two fractions were 
subjected to normal phase column chromatography to purify the sterols. The 
resulting sterol containing fractions were derivatised to the corresponding TMS 
ethers. These were then analysed by GCMS and identified by literature 
comparisons.130-134 The sterol composition of this organism can be seen in Table 
4.2. Cholesterol was the main sterol identified in this organism. As cholesterol is a 
very common sterol, no taxonomic clues could be gathered from the sterol 
composition of this organism. 
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Table 4.2: Sterol Composition of Unidentified Marine Organism. 
 
Sterol      Structure Composition (%) 
 
Cholesterol 223b 54.6
23,24-Dimethylcholest-5,24-dien-3B-ol 223j 12.6
24-Methylcholest-5,24(28)-dien-3B-ol 223f 5.4
Cholestanol 222b 4.4
24-Ethylcholest-5-en-3B-ol 223e 4.4
24-Methylcholest-5-en-3B-ol 223h 4.3
24-Methylcholest-3B-ol 222h 4.0
24-Methylcholest-5,22-dien-3B-ol 223c 2.1
24-Ethylcholest-5,24(28)-dien-3B-ol 223g 1.7
24-Ethylcholest-22-en-3B-ol 222i 1.2
24-Ethylcholest-5,22-dien-3B-ol 223i 1.1
Cholesta-5,24-dien-3B-ol 223k 1.0
Unidentified 3.2
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Chapter Five 
Experimental 
 
5.1  General Experimental Methods 
Nuclear Magnetic Resonance (NMR) spectra were acquired on a Bruker 
DRX-400 spectrometer (1H NMR data at 400.13 MHz and 13C NMR data at 
100.62 MHz). Chemical shifts recorded in ppm were referenced to the appropriate 
solvent signal: CDCl3 1H 7.26 ppm, 13C 77.06 ppm. Standard pulse sequences 
were used for HMBC, HSQC, COSY and NOESY experiments. 
 
High Resolution Electro Spray Mass Spectrometry (HRESMS) data was acquired 
on a Bruker Daltonics MicrOTOF™ spectrometer which uses electrospray 
ionisation and time-of-flight for ion separation. Samples were dissolved in 
distilled methanol at a concentration of <0.1 mg/mL. The solution was filtered 
before being injected directly into the machine. The machine was calibrated 
before each session with a sodium formate standard solution. Between samples 
the system was flushed with methanol until no residual peaks could be seen.   
 
Unit cell dimensions and intensity data for X-ray Crystallography were obtained 
on a Bruker-Nonius Apex II CCD diffractometer, at the University of Canterbury, 
at 93 K.  
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Thin Layer Chromatography (TLC) was performed by applying a solution of a 
sample dissolved in methanol to Macherey-Nagel aluminium backed silica TLC 
plates with drawn glass capillaries. 
 
All Liquid Chromatography Mass Spectrometry (LCMS) samples were run using 
a ThermoFinnigan LCQ Advantage ion trap mass spectrometer with electrospray 
ionisation, a Surveyor HPLC with auto sampler and a photodiode array UV 
detector using a Phenomex® prodigy 5µL ODS 3100A column with a matching 
guard. The tuning file for the mass spectrometer was optimised using cholesterol. 
The liquid chromatography gradient was optimised using a sample of Pterocella 
vesiculosa (05-TT1-01 crude extract) in order to distinguish pterocellin A and 
pterocellin B separately. 
 
Gas Chromatography Mass Spectrometry (GCMS) analysis was performed on a 
Hewlett Packard 6890 gas chromatograph instrument coupled to a HP 5973 mass 
selective detector.  The column used was a Phenomenex® ZB-5 Zebron capillary 
GC column (30 m x 0.25 mm diameter x 0.25 µL film thickness.) 
For derivatised sterol analysis, the GC oven temperature programme is outlined in 
Table 1.   
 
Table 5.1. GC Oven Temperature Programme for Derivatised Sterols. 
Level  Rate (°C/min) Final temperature (°C) Hold (min) 
1 0  100   0.5 
2 20  220   2 
3 2  295   10 
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Ultraviolet/visible absorbance data was obtained using a Varian CARY 100 
Ultra-violet/visible spectrophotometer. The wavelengths between 800-200 nm 
were scanned at a rate of 60 nm/second. 
 
For reversed phase column chromatography C-18 material (30 g) was packed into 
the glass column in a methanol slurry. The column was equilibrated from 
methanol to water prior to loading. The material was applied dry to the top of the 
column which was run under N2 (g) pressure with a steep steeped gradient from 
water to methanol to dichloromethane. 
 
For size exclusion column chromatography Sephadex LH-20 material in a 
methanol slurry was packed into size exclusion columns. Prior to use the column 
was flushed with methanol (250 mL). The material was applied to the top of the 
column as a concentrated solution and then eluted with methanol. The collected 
fractions were rotary evaporated to remove solvent and then blown down with N2 
(g) to ensure dryness. 
 
For Normal Phase column chromatography the columns were packed with Davisil 
35-70 µm silica, (20-25 g). The material was added to the column dissolved in the 
minimum amount of petroleum ether. The elution gradient started at 100 % 
petroleum ether then graduated to 100 % ethyl acetate. The fractions were dried 
down under N2 (g). 
 
All solvents used were bulk drum grade solvents that had been distilled prior to 
use. All lyophilisation was carried out using a LABCONCO® freeze dry system. 
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Rotary evaporation was carried out using a BÜCHI Rotovapor R110 rotary 
evaporator with a BÜCHI 461 water bath at 40 °C. Samples were macerated with 
a Kunkel Ultra Turrax T25 handheld blender.  
 
5.2 Work Described in Chapter Two 
5.2.1 Collection and Extraction of Pterocella vesiculosa 
The red feathery bryozoan identified as P. vesiculosa was collected from the 
Alderman Islands by self contained underwater breathing apparatus (SCUBA) in 
2001. A voucher (AI201-03) is kept in the Chemistry department of the 
University of Waikato. The bryozoan (1.44 kg wet weight) was exhaustively 
extracted by soaking in dichloromethane (800 mL per extraction). The solvent 
was removed and replaced daily for 7 days. The majority of the solvent was 
removed by rotary evaporation and then the sample was lyophilised to yield a 
dark reddish purple extract (1.42 g).  
 
5.2.2 Isolation of Pterocellin H (188) and Pterocellin I (189) 
The crude extract of P. vesiculosa (1.42 g) was fractionated using a C-18 reversed 
phase column (75 g) with a water to methanol to dichloromethane solvent 
gradient. 
 
The third fraction from this column showed coloured spots on the TLC indicative 
of pterocellins. This fraction was then subjected to size exclusion chromatography 
on a Sephadex LH-20 gel column (35 g) eluted with methanol. Fractions 4-6 from 
this column showed a purple dot on TLC (ethyl acetate: methanol, 5:1). Analysis 
of these fractions by NMR spectroscopy indicated that fraction 4 contained 
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pterocellin H (188) with minor impurities, fraction 5 contained a mixture of 
pterocellins H (188) and I (189) and fraction 6 contained pterocellin I (189) with 
minor impurities. 
 
Pterocellin H (188) was isolated as a dark red amorphous solid (6.0 mg) 4.3 x 10-4 
% wet weight. For 1H and 13C NMR data (CDCl3) see Table 2.1. COSY H3↔H4, 
H1’↔H2’, H2’↔H3’, H2’↔H4’. HRESMS m/z [M+Na]+ 365.1512 (100 %) 
(Calculated for C19H22N2O4Na = 365.1471) m/z [M+H]+ 343.1692 (71.9 %) 
(Calculated for C19H23N2O4 = 343.1652). UV data and optical rotation 
measurements are yet to be obtained for this compound. 
 
Pterocellin I (189) was isolated as a dark red amorphous solid (7.2 mg) 5.1 x 10-4 
% wet weight. For 1H and 13C NMR data (CDCl3) see Table 2.2. COSY H3↔H4, 
H3’↔H4’. HRESMS m/z [M+Na]+ 399.1301 (100 %) (Calculated for 
C22H20N2O4Na = 399.1315) m/z [M+H]+ 377.1436 (36.8 %) (Calculated for 
C22H21N2O4 = 377.1495). UV data and optical rotation measurements are yet to be 
obtained for this compound. 
 
5.2.3 Isolation of 1-methyl-5-bromo-8-methoxy-β-carboline (190) 
The crude extract of P. vesiculosa (1.41 g) was fractionated using a C-18 reversed 
phase column (75 g) with a water to methanol to dichloromethane solvent 
gradient. 
 
Fraction 10 from this separation (240.8 mg) was subjected to size exclusion 
chromatography using a column packed with Sephadex LH-20 (150 g). The 
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fractions were eluted with methanol. Fraction 10 from this column (42.6 mg) 
showed an intense orange spot on the TLC plate (ethyl acetate:methanol, 5:1). 1H 
NMR spectroscopy of this fraction indicated a sample containing 1-methyl-5-
bromo-8-methoxy-β-carboline (190).  
 
1-Methyl-5-bromo-8-methoxy-β-carboline (190) was isolated as small square 
yellow crystals (42.6 mg) 3.0 x 10-3 % wet weight. For 1H and 13C NMR data 
(CDCl3) see Table 2.4. COSY H6↔H7, NOESY H6↔H7, H7↔H10. HRESMS 
m/z  [M+H]+ 291.0142 (100 %) (Calculated for C13H12N2OBr79 = 291.0128) and 
293.0124 (94.2 %) (Calculated for C13H12N2OBr81 = 293.0108). [M+Na]+ 
312.9971 (26.2 %) (Calculated for C13H11N2OBr79Na = 312.9947) and 314.9989 
(24.1 %) (Calculated for C13H11N2OBr81Na = 314.9927). λ max (MeOH) 487, 
353, 340, 293, 288 nm (log ε 3.27, 4.61, 4.66, 4.60, 4.72), λ max (KOH/MeOH) 
388, 373, 357, 298, 290 nm (log ε 4.39, 4.48, 4.43, 4.74, 4.72). 
 
5.2.4 Recrystallisation of 1-Methyl-5-bromo-8-methoxy-β-carboline (190) 
Yellow square crystals suitable for X-ray diffraction were obtained by vapour 
diffusion of heptane into a toluene solution containing the sample at room 
temperature. These were sent to the University of Canterbury for X-ray 
crystallography. 
 
5.2.5 Solving of X-ray crystal structure of 1-methyl-5-bromo-8-methoxy-β- 
carboline (190) 
The structure was solved by the direct methods option of SHELXS-97,121 with the 
position of the bromine atom initially found. All other atoms (excluding the 
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methyl hydrogens) of the main molecule and solvent molecule were found by a 
series of difference maps. Full matrix least-squares refinement (SHELXL-97)122 
was based upon F02 with all non-hydrogen atoms anisotropic and methyl 
hydrogens in calculated positions. Other hydrogen atoms were located from 
difference maps and were refined normally. Convergence gave R1 = 0.0316         
[I < 2σ (I)] and wR2 = 0.0848 (all data). Goodness of fit = 1.074. 
 
5.3 Work Described in Chapter Three 
5.3.1 Collection and Extraction for Chemical Survey 
Samples were collected by SCUBA from Ohinau Island and Devil’s Point in the 
Mercury Islands, from Homestead Reef and Spanish Arch at White Island, and 
also from the Sieve, Tom’s Tool, Maori Chief, Orca Bay and Honeycomb in the 
Alderman Islands in 2005. A sub-sample (about 2 g) was taken from each sample 
in the collection. The material was extracted exhaustively, each time being 
macerated in methanol:dichloromethane (3:1, 25 mL). The extracts were 
combined then freeze-dried. About 10 mg of the crude extract was submitted to 
the University of Canterbury for bioassay as described in Section 1.4.  
 
5.3.2 TLC Analysis of Crude Extracts 
Each sample was put onto three plates, each of which was run with a different 
solvent system. Solvent systems that were used were ethyl acetate:methanol (5:1), 
petroleum ether:ethyl acetate (2:1) and petroleum ether:ethyl acetate (4:1). The 
plates were air dried and analysed by eye as well as under UV light at 254 nm and 
312 nm. 
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5.3.3 Chemical Survey of New Zealand Marine Organisms 
Crude extract (20 mg) was dissolved in methanol (1 mL) and this solution was 
then filtered. The filter was rinsed with methanol (2 x 0.5 mL). 
 
Two gradient programs were used for LCMS analysis of the crude extracts. All 
Pterocella vesiculosa samples were run on the gradient program set out in Table 
5.2. All other samples were run on a slightly longer program set out in Table 5.3. 
Solvent A was acetonitrile and Solvent B was deionised water with 0.05 % 
trifluoroacetic acid (TFA). The photodiode array detector acquired data from 190 
to 800 nm, the mass spectrometer obtained data in the m/z range 150 to 1400. A 
three minute isocratic methanol blank (10 % acetonitrile, 90 % deionised water 
containing 0.05 % TFA) interceded each run to assist with reproducibility. All 
samples were run in duplicate. 
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Table 5.2: LCMS Gradient Programme for Pterocella vesiculosa. 
 
Time (min) Solvent A (%)  Solvent B (%) 
 (acetonitrile)  (deionised water with 0.05 %TFA) 
0   10 90    
2   10 90 
22 100   0  
35 100   0  
40   10 90 
 
Table 5.3: LCMS Gradient Programme for all Other Survey Samples. 
 
Time (min) Solvent A (%)  Solvent B (%) 
 (acetonitrile)  (deionised water with 0.05 %TFA) 
0   10 90    
2   10 90 
27 100   0  
39 100   0  
45   10 90 
 
5.4 Work Described in Chapter Four 
5.4.1 Collection and Extraction of a Sponge from the Darwinellidae Family 
(05-SA1-10) 
The purple finger sponge was collected from the Spanish Arch, White Island in 
2005 by SCUBA and was stored frozen. The sample (48.1 g wet weight) was 
exhaustively extracted by blending in methanol: dichloromethane (3:1) (200 mL 
per extraction). The majority of the solvent was removed by rotary evaporation 
before the sample was freeze-dried to yield a dark brown-red extract (1.94 g). A 
voucher sample (2 g) of this animal (05-SA1-10) is kept in the Chemistry 
Department at the University of Waikato.  
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5.4.2 Studies of a Sponge from the Family Darwinellidae 
The crude extract (1.94 g) of the sponge was separated by flash column 
chromatography on C-18 reversed phase silica (30 g) eluted with a solvent 
gradient from water to methanol to dichloromethane. Fraction 5 showed 
considerable activity against the P388 cell line (IC50 = 1522 ng/mL). TLC analysis 
revealed no distinctive spots. Fraction 5 (37.4 mg) was then subjected to further 
separation on a Sephadex LH-20 size exclusion column (35 g) using methanol as 
the solvent. Fractions 6 and 7 from this column showed good activity against the 
P388 cell line (IC50 values = 751 and 508 ng/mL respectively), TLC analysis did 
not reveal any significant spots. 1H NMR and HRESMS analysis indicated that a 
mixture of compounds was present in these two fractions. In an attempt to 
separate this mixture, fractions 6 and 7 (11.9 mg) were combined and subjected to 
further size exclusion chromatography (Sephadex LH-20, 35 g) resulting in the 
compounds of interest co-eluting in fractions 17-20. These fractions were again 
combined (8.7 mg) and put through a size exclusion column (Sephadex LH-20, 35 
g) with smaller aliquots being collected. HRESMS and 1H NMR revealed that 
these compounds co-elute and could not be separated solely by size exclusion 
chromatography. The separation tree for this sample can be seen in Appendix 
Five. 
 
5.4.3 Sterols from a Sponge of the Family Darwinellidae 
Analysis by TLC of fractions 134.7, 134.8 and 134.9 indicated the presence of 
sterols. These three fractions were combined (total weight 107.9 mg) and run 
through a silica column (Davisil 35-70 µm silica, 23.14 g).  TLC analysis of 
fractions 165.7-165.10 indicated the presence of sterols. These fractions were 
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combined for derivatisation (total weight 26.5 mg).  The combined fraction was 
dissolved in trimethylsilyl (TMS) imidazole (300 μL). The mixture was sonicated 
(2 minutes) then heated (60 °C for 1 hour). Heptane was added to the solution (1 
mL), shaken and then the heptane removed into a new vial. Distilled water (1 mL) 
was added to the heptane mixture. This was then put on the vortex shaker (5 
seconds) and then centrifuged (5 minutes). The layer of water was removed, 
CaCO3 was added to further dry the solution then the heptane layer was 
transferred into a vial for GCMS analysis. 
 
5.4.4 Collection and Extraction of an Unidentified Marine Organism 
(05-OI1-02) 
Sample 05-OI1-02, an amorphous blue lump, was collected by SCUBA from 
Ohinau Island in the Mercury Islands in 2005 and stored frozen until required. 
The sample (19.01g wet weight) was exhaustively extracted by repeatedly 
blending in methanol/dichloromethane (3:1), (200 mL per extraction) until the 
solvent was colourless. The majority of the solvent was removed by rotary 
evaporation before the sample was lyophilised to yield a dark brown green extract 
(1.65 g). A voucher sample (2 g) of this animal (05-OI1-02) is kept in the 
Chemistry Department at the University of Waikato. 
 
5.4.5 Studies of Unidentified Marine Organism 
The crude extract (1.65 g) of this sample was separated on C-18 reversed phase 
silica (30 g) eluted with a solvent gradient of water to methanol to 
dichloromethane. Fractions 4-7 showed activity in the P388 antitumour assay, 
(IC50 values were 12030, 3032, 4215, 17760 ng/mL respectively). These four 
Chapter 5 Experimental 123 
fractions were combined (195.9 mg) and subjected to size exclusion 
chromatography on Sephadex LH-20 material (150 g) with methanol as the 
solvent. Fractions 4-5 displayed activity in the P388 assay. TLC analysis of these 
fractions under UV light indicated that multiple spots were present and 1H NMR 
spectroscopic experiments showed a dominance of a ‘grease’ signal in the 
spectrum of both fractions. These fractions were combined (118.6 mg) and 
dissolved in 95 % ethanol, then partitioned against petroleum ether, 1H NMR 
analysis of the resulting fractions indicated removal of grease had been 
unsuccessful so the fractions were recombined and subject to further size 
exclusion chromatography (Sephadex LH-20, 150 g) with methanol as the solvent. 
Biological assay results indicated that the P388 inhibitory activity was present in 
fractions 9-18. TLC analysis of these compounds revealed multiple spots in all 
fractions. The 1H NMR spectrum contained a dominant peak at 1.25 ppm, typical 
of grease, as well as small, indeterminable signals. The separation tree for this 
unidentified marine organism can be seen in Appendix Five. 
 
5.4.6 Sterols Identification of Unidentified Marine Organism (05-OI1-02) 
TLC analysis of fractions 129.8 and 129.9 indicated the presence of sterols. These 
two fractions were combined (total weight 127.2 mg) and then subjected to 
normal phase chromatography on a silica column (Davisil 35-70 µm silica, 21.46 
g). The combined fractions were added to the column dissolved in the minimum 
amount of petroleum ether. TLC analysis indicated the presence of sterols in 
fractions 162.8-162.11. These fractions were combined (38.7 mg) and sterol 
derivatisation was performed as detailed in Section 5.4.3. 
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Appendices 
 
 
 
Appendix One: NMR Spectra of Pterocellin H 
 
A 1.1: 13C NMR Spectrum of pterocellin H recorded in CDCl3 
 
A 1.2: COSY NMR spectrum of pterocellin H recorded in CDCl3 
 
A 1.3: HMBC NMR spectrum of pterocellin H recorded in CDCl3 
 
A.1.4: HSQC NMR spectrum of pterocellin H recorded in CDCl3
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Appendix Two: NMR Spectra of Pterocellin I  
 
A 2.1: 13C NMR spectrum of pterocellin I recorded in CDCl3 
 
A 2.2: COSY NMR spectrum of pterocellin I recorded in CDCl3 
 
A 2.3: HMBC NMR spectrum of pterocellin I recorded in CDCl3 
 
A 2.4: HSQC NMR spectrum of pterocellin I recorded in CDCl3 
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Appendix Three: NMR Spectra of 1-Methyl-5-bromo-8-
methoxy-β-carboline (190) 
 
A 3.1: 13C NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-
carboline (190) in CDCl3 
 
A 3.2: NOESY NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-
carboline (190) in CDCl3 
 
A 3.3: HSQC NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-
carboline (190) in CDCl3 
 
A 3.4: HMBC NMR spectrum of 1-methyl-5-bromo-8-methoxy-β-
carboline (190) in CDCl3 
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Appendix Four: Biological Assay Results from Survey 
(Chapter Three) 
 
A 4.1: P388 and antiviral/cytotoxicity results for marine samples 
collected in 2005. 
 
A 4.2: Antimicrobial and antifungal results for marine samples 
collected in 2005. 
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A 4.1: P388 and antiviral/cytotoxicity results for marine samples collected in  
2005.a 
Sample P388 HSVb HCytb PV1b PCytb
05-TS1-01 > 125000 ND ND ND ND 
05-TS1-02 > 125000 ND ND ND ND 
05-TS1-03 > 125000 ND ND ND ND 
05-TS1-04 121357 ND ND ND ND 
05-TT1-01 > 125000 ND ND ND ND 
05-TT1-02 > 125000 ND ND ND ND 
05-TT1-03 92827 ?* 2+ ND ND 
05-TT1-04 > 125000 ND ND ND ND 
05-TT1-05 > 125000 ND ND ?* +,8 
05-TT1-06 61181 ?* 2+,6 ?* +,6 
05-MC1-01 > 125000 ?* 2+,6 ?* +,6 
05-MC1-02 > 125000 ND ND ND ND 
05-MC1-03 > 125000 ND ND ND ND 
05-MC1-04 > 125000 ND ND ND ND 
05-MC1-05 > 125000 ND ND ND ND 
05-MC1-06 > 125000 ND ND ND ND 
05-MC1-07 > 125000 ND ND ND ND 
05-OB1-01 > 125000 ND ND ND ND 
05-OB1-02 > 125000 ND ND 3+ +*,7 
05-OB1-03 117797 ND ND ND ND 
05-OB1-04 > 125000 ND ND ND ND 
05-OB1-05 > 125000 ND ND ND ND 
05-OB1-06 > 125000 ND ND ND ND 
05-OB1-07 > 125000 ND ND ND ND 
05-HC1-01 > 125000 ND ND ND ND 
05-HC1-02 > 125000 ND ND ND ND 
05-HC1-03 > 125000 ND ND ND ND 
05-HC1-04 > 125000 ND ND ND ND 
05-HC1-05 > 125000 ND ND ND ND 
05-HC1-06 > 125000 ND ND ND ND 
05-HC1-07 > 125000 ND ND ND ND 
05-OI1-01 > 125000 ND ND ND ND 
05-OI1-02 39141 ?* 2+,8 ?* 3+,8 
05-OI1-03 > 125000 ND ND ND ND 
05-OI1-05 > 125000 ND ND ND ND 
05-OI1-06 > 125000 ND ND ND ND 
05-OI1-07 > 125000 ND ND ND ND 
05-OI1-08 > 125000 ND ND ND ND 
05-OI1-09 114341 ? 4+,6 ? 4+,6 
05-OI1-10 114341 ND ND ND ND 
05-OI1-11 110986 ND ND ND ND 
05-OI1-12 61181 ND ND ND ND 
05-OI1-13 > 125000 ND ND ND ND 
05-DP1-01 > 125000 ND ND ND ND 
05-DP1-02 > 125000 ND ND ND ND 
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Sample P388 HSVb HCytb PV1b PCytb
05-DP1-03 > 125000 ND ND ND ND 
05-DP1-04 77639 ND ND ND ND 
05-DP1-05 > 125000 ND ND ND ND 
05-DP1-06 > 125000 ND ND ND ND 
05-DP1-07 > 125000 ND ND ND ND 
05-DP1-08 > 125000 ND ND ND ND 
05-DP1-09 > 125000 ND ND ND ND 
05-DP1-10 > 125000 ND ND ND ND 
05-DP1-11 > 125000 ND ND ND ND 
05-DP1-12 > 125000 ? 4+,6 ? 4+,6 
05-DP1-13 > 125000 ? 4+,6 ? 4+,6 
05-DP1-14 > 125000 ND ND ND ND 
05-DP1-15 > 125000 ND ND ND ND 
05-DP1-17 > 125000 ND ND ND ND 
05-DP1-18 68920 ND ND ND ND 
05-DP1-19 > 125000 ND ND ND ND 
05-HR1-01 > 125000 ND ND ND ND 
05-HR1-02 82403 ND ND ND ND 
05-HR1-03 > 125000 ND ND ND ND 
05-HR1-04 > 125000 ND ND ND ND 
05-HR1-05 > 125000 ND ND ND ND 
05-HR1-06 65196 ND ND ND ND 
05-HR1-07 > 125000 ND ND ND ND 
05-HR1-08 > 125000 ND ND ND ND 
05-HR1-09 > 125000 ND ND ND ND 
05-HR1-10 > 125000 ND ND ND ND 
05-HR1-11 > 125000 ND ND ND ND 
05-SA1-01 > 125000 ND ND ND ND 
05-SA1-02 71004 ND ND ND ND 
05-SA1-03 > 125000 ND ND ND ND 
05-SA1-04 121357 ND ND ND ND 
05-SA1-05 121357 ND ND ND ND 
05-SA1-06 75361 ND ND ND ND 
05-SA1-07 > 125000 ND ND ND ND 
05-SA1-08 > 125000 ND ND ND ND 
05-SA1-09 > 125000 ND ND ND ND 
05-SA1-10 52717 ND ND ND ND 
05-SA1-11 77639 ND ND ND ND 
05-SA1-12 > 125000 ND ND ND ND 
a refer to Section 3.2 for details of assays and Tables 3.1 and 3.2 for explaination 
of results 
b all antiviral/cytotoxicity assays at 400 μg/well 
 
 Appendices 142 
A 4.2: Antimicrobial and antifungal results for marine samples collected in 2005.a 
Sample E colib B subc P aerd C albe T mentf C resg
05-TS1-01 NDh 1 ND ND ND ND 
05-TS1-02 ND 1 ND ND ND ND 
05-TS1-03 ND ND ND ND ND ND 
05-TS1-04 ND ND ND ND ND ND 
05-TT1-01 ND ND ND ND ND ND 
05-TT1-02 ND 2 ND ND ND ND 
05-TT1-03 ND 1 ND ND ND ND 
05-TT1-04 ND 1 ND ND ND ND 
05-TT1-05 ND ND ND ND ND ND 
05-TT1-06 ND 1 ND ND 1 ND 
05-MC1-01 ND 1 ND ND ND ND 
05-MC1-02 ND 1 ND ND ND ND 
05-MC1-03 ND 1 ND ND ND ND 
05-MC1-04 ND 1 ND ND ND ND 
05-MC1-05 ND 1 ND ND ND ND 
05-MC1-06 ND ND ND ND ND ND 
05-MC1-07 ND ND ND ND ND ND 
05-OB1-01 ND 1 ND ND ND ND 
05-OB1-02 ND 2 ND ND ND ND 
05-OB1-03 ND ND ND ND ND ND 
05-OB1-04 ND ND ND ND ND ND 
05-OB1-05 ND ND ND ND ND ND 
05-OB1-06 ND ND ND ND ND ND 
05-OB1-07 ND ND ND ND ND ND 
05-HC1-01 ND 2 ND ND ND ND 
05-HC1-02 ND 2 ND ND ND ND 
05-HC1-03 ND 2 ND ND ND ND 
05-HC1-04 ND ND ND ND ND ND 
05-HC1-05 ND ND ND ND ND ND 
05-HC1-06 ND ND ND ND ND ND 
05-HC1-07 ND ND ND ND ND ND 
05-OI1-01 ND ND ND ND ND ND 
05-OI1-02 ND 1 ND 1 1 ND 
05-OI1-03 ND ND ND ND ND ND 
05-OI1-05 ND ND ND ND ND ND 
05-OI1-06 ND ND ND ND ND ND 
05-OI1-07 ND ND ND ND ND ND 
05-OI1-08 ND ND ND ND ND ND 
05-OI1-09 ND ND ND ND ND ND 
05-OI1-10 ND ND ND ND ND ND 
05-OI1-11 ND ND ND ND ND ND 
05-OI1-12 ND ND ND ND 1 ND 
05-OI1-13 ND ND ND ND 1 ND 
05-DP1-01 ND ND ND ND ND ND 
05-DP1-02 ND ND ND ND 3 ND 
05-DP1-03 ND ND ND ND 3 ND 
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Sample E colib B subc P aerd C albe T mentf C resg
05-DP1-04 ND ND ND ND 3 ND 
05-DP1-05 ND ND ND ND ND ND 
05-DP1-06 ND ND ND ND ND ND 
05-DP1-07 ND ND ND 5 ND ND 
05-DP1-08 ND ND ND ND 1 ND 
05-DP1-09 ND ND ND ND ND ND 
05-DP1-10 ND ND ND ND ND ND 
05-DP1-11 ND ND ND ND ND ND 
05-DP1-12 ND ND ND ND ND ND 
05-DP1-13 ND ND ND ND ND ND 
05-DP1-14 ND ND ND ND ND ND 
05-DP1-15 ND ND ND ND ND ND 
05-DP1-17 ND ND ND ND ND ND 
05-DP1-18 ND ND ND ND ND ND 
05-DP1-19 ND ND ND ND ND ND 
05-HR1-01 ND ND ND ND ND ND 
05-HR1-02 ND 3 ND ND ND ND 
05-HR1-03 ND ND ND ND ND ND 
05-HR1-04 ND ND ND ND ND ND 
05-HR1-05 ND ND ND ND ND ND 
05-HR1-06 ND ND ND ND ND ND 
05-HR1-07 ND 2 ND ND ND ND 
05-HR1-08 ND ND ND ND ND ND 
05-HR1-09 ND ND ND ND ND ND 
05-HR1-10 ND ND ND ND ND ND 
05-HR1-11 ND ND ND ND ND ND 
05-SA1-01 ND ND ND ND ND ND 
05-SA1-02 ND ND ND ND ND ND 
05-SA1-03 ND ND ND ND ND ND 
05-SA1-04 ND ND ND ND ND ND 
05-SA1-05 ND ND ND ND ND ND 
05-SA1-06 ND 3 ND ND ND ND 
05-SA1-07 ND ND ND ND ND ND 
05-SA1-08 ND ND ND ND ND ND 
05-SA1-09 ND ND ND ND ND ND 
05-SA1-10 ND 1 ND ND ND ND 
05-SA1-11 ND 5 ND ND ND ND 
05-SA1-12 ND ND ND 3 ND ND 
a refer to Section 3.2 for details of assays, all the assays run at 400 μg/disk. 
b Escherichia coli,  c Bacillus subtilis, d Pseudomonas aeruginosa,  e Candida 
albicans, f Trichophyton mentagrophytes, gCladosporium resinae 
h indicates no death 
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 Appendix Five: Separation trees  
 
A 5.1: Separation tree for the extract of Pterocella vesiculosa 
 
A 5.2: Separation tree for the extract of the Darwinellidae species.                   
(05-SA1-10) 
 
A 5.3: Separation tree for the extract of an unidentified marine                                           
organism (05-OI1-02)  
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